| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Fc-gamma receptor I complex binding | 2.56e-06 | 7 | 333 | 4 | GO:0034988 | |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 6.57e-06 | 17 | 333 | 5 | GO:0022848 | |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 3.29e-05 | 23 | 333 | 5 | GO:0015464 | |
| GeneOntologyMolecularFunction | acetylcholine binding | 4.82e-05 | 13 | 333 | 4 | GO:0042166 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 7.45e-05 | 43 | 333 | 6 | GO:0005231 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC3 HSP90B2P TDRD9 NAIP AK9 HELB ABCB4 KIF28P DDX60L DNAH5 DNAH9 ATP8B3 DDX49 ATP13A1 SMCHD1 CHD9 DHX30 ATP2C1 KIF1C | 1.67e-04 | 441 | 333 | 19 | GO:0016887 |
| GeneOntologyMolecularFunction | complement component C3b receptor activity | 2.77e-04 | 2 | 333 | 2 | GO:0004877 | |
| GeneOntologyMolecularFunction | S-malonyltransferase activity | 2.77e-04 | 2 | 333 | 2 | GO:0016419 | |
| GeneOntologyMolecularFunction | malonyltransferase activity | 2.77e-04 | 2 | 333 | 2 | GO:0016420 | |
| GeneOntologyMolecularFunction | tRNA-4-demethylwyosine synthase activity | 2.77e-04 | 2 | 333 | 2 | GO:0102521 | |
| GeneOntologyMolecularFunction | 3-oxoacyl-[acyl-carrier-protein] synthase activity | 2.77e-04 | 2 | 333 | 2 | GO:0004315 | |
| GeneOntologyMolecularFunction | [acyl-carrier-protein] S-malonyltransferase activity | 2.77e-04 | 2 | 333 | 2 | GO:0004314 | |
| GeneOntologyMolecularFunction | complement component C4b receptor activity | 2.77e-04 | 2 | 333 | 2 | GO:0001861 | |
| GeneOntologyMolecularFunction | prosaposin receptor activity | 2.77e-04 | 2 | 333 | 2 | GO:0036505 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC3 HSP90B2P TDRD9 NAIP AK9 HELB ABCB4 UBA1 KIF28P DDX60L DNAH5 DNAH9 ATP8B3 DDX49 ATP13A1 SMCHD1 CHD9 DHX30 DNAH1 ATP2C1 SMARCA1 ACSL5 KIF1C | 2.78e-04 | 614 | 333 | 23 | GO:0140657 |
| GeneOntologyMolecularFunction | immunoglobulin receptor binding | 3.63e-04 | 21 | 333 | 4 | GO:0034987 | |
| GeneOntologyMolecularFunction | transporter activity | NAT2 ABCC3 SLC6A19 SIDT1 SLC29A2 SLC18B1 CHRNA3 CHRNA4 CHRNA5 RYR1 CHRNB2 GJD4 ABCB4 CFHR4 TRPM5 SLC5A6 SCN4B KCNJ16 PLEKHA8 ATP8B3 CHRNA6 CACNB3 ATP13A1 SLC44A2 SLCO1B1 SLC7A14 SLC25A22 SLC6A11 ATP2C1 SLC15A1 SLC45A3 P2RX2 SLC18A2 SLC25A1 SLC24A1 M6PR SLC2A11 SLC25A31 | 4.64e-04 | 1289 | 333 | 38 | GO:0005215 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 5.80e-04 | 140 | 333 | 9 | GO:0099094 | |
| GeneOntologyMolecularFunction | complement component C4b binding | 8.23e-04 | 3 | 333 | 2 | GO:0001855 | |
| GeneOntologyMolecularFunction | alpha-catenin binding | 9.04e-04 | 12 | 333 | 3 | GO:0045294 | |
| GeneOntologyMolecularFunction | complement component C3b binding | 9.04e-04 | 12 | 333 | 3 | GO:0001851 | |
| GeneOntologyBiologicalProcess | orbitofrontal cortex development | 4.10e-06 | 3 | 331 | 3 | GO:0021769 | |
| GeneOntologyBiologicalProcess | positive regulation of type I hypersensitivity | 4.33e-06 | 8 | 331 | 4 | GO:0001812 | |
| GeneOntologyBiologicalProcess | regulation of type I hypersensitivity | 7.70e-06 | 9 | 331 | 4 | GO:0001810 | |
| GeneOntologyBiologicalProcess | positive regulation of type IIa hypersensitivity | 1.27e-05 | 10 | 331 | 4 | GO:0001798 | |
| GeneOntologyBiologicalProcess | type I hypersensitivity | 1.27e-05 | 10 | 331 | 4 | GO:0016068 | |
| GeneOntologyBiologicalProcess | positive regulation of type II hypersensitivity | 1.27e-05 | 10 | 331 | 4 | GO:0002894 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoplasmic translation | 1.27e-05 | 10 | 331 | 4 | GO:2000766 | |
| GeneOntologyBiologicalProcess | neurotransmitter uptake | 1.85e-05 | 52 | 331 | 7 | GO:0001504 | |
| GeneOntologyBiologicalProcess | regulation of type IIa hypersensitivity | 1.97e-05 | 11 | 331 | 4 | GO:0001796 | |
| GeneOntologyBiologicalProcess | regulation of type II hypersensitivity | 1.97e-05 | 11 | 331 | 4 | GO:0002892 | |
| GeneOntologyBiologicalProcess | behavioral response to nicotine | 1.97e-05 | 11 | 331 | 4 | GO:0035095 | |
| GeneOntologyBiologicalProcess | calcium ion transport | CHRNA4 STAC RYR1 CHRNB2 TRPM5 PLCB4 WNK3 AKAP6 CACNB3 DRD2 ANK2 CAMK2D CAMK2G FBXO11 CAV1 CASK ATP2C1 P2RY6 P2RX2 SLC24A1 CDK5 PLCE1 | 2.79e-05 | 509 | 331 | 22 | GO:0006816 |
| GeneOntologyBiologicalProcess | immunoglobulin mediated immune response | ERCC1 IGLL5 CFHR4 SUPT6H CR1 CR1L IGHG1 IGHG2 IGHG3 IGHG4 IGLC1 IGLC2 IGLC3 IGLC6 | 2.86e-05 | 235 | 331 | 14 | GO:0016064 |
| GeneOntologyBiologicalProcess | B cell receptor signaling pathway | 3.92e-05 | 79 | 331 | 8 | GO:0050853 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 4.00e-05 | 5 | 331 | 3 | GO:0006711 | |
| GeneOntologyBiologicalProcess | antibody-dependent cellular cytotoxicity | 4.15e-05 | 13 | 331 | 4 | GO:0001788 | |
| GeneOntologyBiologicalProcess | entrainment of circadian clock by photoperiod | 4.21e-05 | 25 | 331 | 5 | GO:0043153 | |
| GeneOntologyBiologicalProcess | B cell mediated immunity | ERCC1 IGLL5 CFHR4 SUPT6H CR1 CR1L IGHG1 IGHG2 IGHG3 IGHG4 IGLC1 IGLC2 IGLC3 IGLC6 | 4.32e-05 | 244 | 331 | 14 | GO:0019724 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ABCC3 TCAF1 SLC6A19 SIK1 SLC18B1 CHRNA3 CHRNA4 STAC CHRNA5 RYR1 CHRNB2 TRPM5 SLC5A6 NECTIN1 SCN4B KCNJ16 PLCB4 WNK3 AKAP6 CHRNA6 CACNB3 DRD2 ANK2 ATP13A1 CAMK2D CAMK2G FBXO11 CAV1 SLCO1B1 CASK TG SLC25A22 SLC6A11 ATP2C1 TMEM168 SLC15A1 P2RY6 P2RX2 SLC18A2 SLC24A1 CDK5 PLCE1 | 4.46e-05 | 1374 | 331 | 42 | GO:0006811 |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | CHRNA3 CHRNA4 CHRNA5 CHRNB2 CHRNA6 CACNB3 DRD2 APP P2RX2 CDK5 | 4.81e-05 | 130 | 331 | 10 | GO:0060079 |
| GeneOntologyBiologicalProcess | import into cell | EPRS1 SIGLEC5 UNC13D SLC29A2 SLC18B1 USP20 MFGE8 PER2 PIK3C3 SLC5A6 KCNJ16 HEATR5B SNX9 WNK3 DPP4 HSPG2 DRD2 ANK2 SIGLEC14 CAV1 APP SLC6A11 IGF2R SLC15A1 P2RY6 SLC18A2 IGHG1 IGHG2 IGHG3 IGHG4 SLC24A1 M6PR ACSL5 CXCR2 CDK5 | 5.78e-05 | 1074 | 331 | 35 | GO:0098657 |
| GeneOntologyBiologicalProcess | complement activation, classical pathway | 6.89e-05 | 44 | 331 | 6 | GO:0006958 | |
| GeneOntologyBiologicalProcess | photoperiodism | 7.49e-05 | 28 | 331 | 5 | GO:0009648 | |
| GeneOntologyBiologicalProcess | type IIa hypersensitivity | 7.73e-05 | 15 | 331 | 4 | GO:0001794 | |
| GeneOntologyBiologicalProcess | positive regulation of hypersensitivity | 7.73e-05 | 15 | 331 | 4 | GO:0002885 | |
| GeneOntologyBiologicalProcess | type II hypersensitivity | 7.73e-05 | 15 | 331 | 4 | GO:0002445 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 7.90e-05 | 6 | 331 | 3 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 7.90e-05 | 6 | 331 | 3 | GO:0046226 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 7.90e-05 | 6 | 331 | 3 | GO:0051552 | |
| GeneOntologyBiologicalProcess | response to decreased oxygen levels | GAD2 CHRNA4 RYR1 CHRNB2 FGFR2 CPEB2 DPP4 HSPG2 DRD2 LIMD1 CAMK2D CAMK2G CAV1 CR1 CR1L P2RX2 CPEB4 | 9.02e-05 | 364 | 331 | 17 | GO:0036293 |
| GeneOntologyBiologicalProcess | complement-dependent cytotoxicity | 1.02e-04 | 16 | 331 | 4 | GO:0097278 | |
| GeneOntologyBiologicalProcess | entrainment of circadian clock | 1.06e-04 | 30 | 331 | 5 | GO:0009649 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ABCC3 TCAF1 SLC6A19 SLC18B1 CHRNA3 CHRNA4 STAC CHRNA5 RYR1 CHRNB2 TRPM5 SLC5A6 SCN4B KCNJ16 PLCB4 WNK3 AKAP6 CHRNA6 CACNB3 DRD2 ANK2 ATP13A1 CAMK2D FBXO11 CAV1 SLC25A22 SLC6A11 ATP2C1 TMEM168 SLC15A1 P2RY6 P2RX2 SLC18A2 SLC24A1 PLCE1 | 1.21e-04 | 1115 | 331 | 35 | GO:0034220 |
| GeneOntologyBiologicalProcess | complement activation | 1.30e-04 | 70 | 331 | 7 | GO:0006956 | |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response to antigenic stimulus | 1.31e-04 | 17 | 331 | 4 | GO:0002866 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | CHRNA3 CHRNA4 CHRNA5 CHRNB2 CHRNA6 CACNB3 DRD2 APP P2RX2 CDK5 | 1.35e-04 | 147 | 331 | 10 | GO:0099565 |
| GeneOntologyBiologicalProcess | early endosome to late endosome transport | 1.43e-04 | 50 | 331 | 6 | GO:0045022 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 1.48e-04 | 121 | 331 | 9 | GO:0051899 | |
| GeneOntologyBiologicalProcess | response to hypoxia | GAD2 CHRNA4 RYR1 CHRNB2 FGFR2 CPEB2 DPP4 HSPG2 DRD2 LIMD1 CAMK2D CAMK2G CAV1 CR1 CR1L P2RX2 | 1.73e-04 | 348 | 331 | 16 | GO:0001666 |
| GeneOntologyBiologicalProcess | regulation of hypersensitivity | 2.09e-04 | 19 | 331 | 4 | GO:0002883 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | RYR1 PLCB4 AKAP6 CACNB3 DRD2 ANK2 CAMK2D CAV1 P2RY6 P2RX2 SLC24A1 PLCE1 | 2.13e-04 | 217 | 331 | 12 | GO:0097553 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC6A19 SIK1 SLC18B1 CHRNA4 STAC RYR1 CHRNB2 TRPM5 SLC5A6 NECTIN1 SCN4B KCNJ16 PLCB4 WNK3 AKAP6 CACNB3 DRD2 ANK2 ATP13A1 CAMK2D CAMK2G FBXO11 CAV1 CASK SLC25A22 SLC6A11 ATP2C1 TMEM168 SLC15A1 P2RY6 P2RX2 SLC18A2 SLC24A1 CDK5 PLCE1 | 2.44e-04 | 1157 | 331 | 35 | GO:0006812 |
| GeneOntologyBiologicalProcess | negative regulation of cytoplasmic translational elongation | 2.57e-04 | 2 | 331 | 2 | GO:1900248 | |
| GeneOntologyBiologicalProcess | fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development | 2.57e-04 | 2 | 331 | 2 | GO:0035607 | |
| GeneOntologyBiologicalProcess | positive regulation of glycolytic process through fructose-6-phosphate | 2.57e-04 | 2 | 331 | 2 | GO:1904540 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport between endosomal compartments | 2.70e-04 | 56 | 331 | 6 | GO:0098927 | |
| GeneOntologyBiologicalProcess | antigen receptor-mediated signaling pathway | CYLD USP9X FYB2 CACNB3 IGHG1 IGHG2 IGHG3 IGHG4 IGLC1 IGLC3 CTLA4 IGLC6 | 2.73e-04 | 223 | 331 | 12 | GO:0050851 |
| GeneOntologyBiologicalProcess | regulation of immunoglobulin mediated immune response | 2.77e-04 | 79 | 331 | 7 | GO:0002889 | |
| GeneOntologyBiologicalProcess | regulation of B cell mediated immunity | 2.77e-04 | 79 | 331 | 7 | GO:0002712 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | HSP90B2P DHRS3 AIMP1 JAK2 PER2 UGT2B10 FGFR1 DPP4 DRD2 UGT1A10 RBM4 UGT1A8 UGT1A7 CAMK2G SLCO1B1 TIPARP CHST8 CASK TG SLC25A22 SLC18A2 PCSK6 FSHB DKK3 | 3.05e-04 | 684 | 331 | 24 | GO:0010817 |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 3.14e-04 | 21 | 331 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | regulation of relaxation of cardiac muscle | 3.20e-04 | 9 | 331 | 3 | GO:1901897 | |
| GeneOntologyBiologicalProcess | response to nicotine | 3.27e-04 | 58 | 331 | 6 | GO:0035094 | |
| GeneOntologyBiologicalProcess | neurotransmitter reuptake | 3.36e-04 | 38 | 331 | 5 | GO:0098810 | |
| GeneOntologyBiologicalProcess | regulation of circadian rhythm | 3.37e-04 | 135 | 331 | 9 | GO:0042752 | |
| GeneOntologyBiologicalProcess | metal ion transport | SLC6A19 SIK1 CHRNA4 STAC RYR1 CHRNB2 TRPM5 SLC5A6 NECTIN1 SCN4B KCNJ16 PLCB4 WNK3 AKAP6 CACNB3 DRD2 ANK2 ATP13A1 CAMK2D CAMK2G FBXO11 CAV1 CASK SLC6A11 ATP2C1 TMEM168 P2RY6 P2RX2 SLC24A1 CDK5 PLCE1 | 3.70e-04 | 1000 | 331 | 31 | GO:0030001 |
| GeneOntologyBiologicalProcess | amine transport | CHRNA3 CHRNA4 CHRNB2 PER2 CHRNA6 DRD2 SLC44A2 SLC15A1 SLC18A2 | 3.76e-04 | 137 | 331 | 9 | GO:0015837 |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transporter activity | 3.80e-04 | 39 | 331 | 5 | GO:1901021 | |
| GeneOntologyBiologicalProcess | regulation of cation channel activity | 3.96e-04 | 138 | 331 | 9 | GO:2001257 | |
| GeneOntologyBiologicalProcess | endosome to lysosome transport | 4.05e-04 | 84 | 331 | 7 | GO:0008333 | |
| GeneOntologyBiologicalProcess | immune response-regulating signaling pathway | CYLD USP9X NAIP OSCAR NCR1 FYB2 CACNB3 CAV1 ALPK1 APP CR1 PPP2CA NMI IGHG1 IGHG2 IGHG3 IGHG4 PAK3 IGLC1 IGLC3 CTLA4 IGLC6 | 4.18e-04 | 615 | 331 | 22 | GO:0002764 |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 4.52e-04 | 10 | 331 | 3 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 4.52e-04 | 10 | 331 | 3 | GO:0009804 | |
| GeneOntologyBiologicalProcess | positive regulation of inflammatory response to antigenic stimulus | 4.53e-04 | 23 | 331 | 4 | GO:0002863 | |
| GeneOntologyBiologicalProcess | humoral immune response mediated by circulating immunoglobulin | 4.71e-04 | 62 | 331 | 6 | GO:0002455 | |
| GeneOntologyBiologicalProcess | dopamine secretion | 4.82e-04 | 41 | 331 | 5 | GO:0014046 | |
| GeneOntologyBiologicalProcess | regulation of membrane repolarization | 4.82e-04 | 41 | 331 | 5 | GO:0060306 | |
| GeneOntologyBiologicalProcess | activation of immune response | CYLD USP9X NAIP CFHR4 FYB2 CACNB3 CAV1 ALPK1 APP CR1 CR1L PPP2CA NMI IGHG1 IGHG2 IGHG3 IGHG4 PAK3 IGLC1 IGLC3 CTLA4 IGLC6 | 4.97e-04 | 623 | 331 | 22 | GO:0002253 |
| GeneOntologyBiologicalProcess | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | ERCC1 UNC13D IGLL5 CFHR4 JAK2 SUPT6H DPP4 CR1 CR1L IGHG1 IGHG2 IGHG3 IGHG4 IGLC1 IGLC2 IGLC3 IGLC6 IL6R | 5.21e-04 | 462 | 331 | 18 | GO:0002460 |
| GeneOntologyBiologicalProcess | phosphatidylinositol-mediated signaling | 5.37e-04 | 24 | 331 | 4 | GO:0048015 | |
| GeneOntologyBiologicalProcess | acute inflammatory response to antigenic stimulus | 5.40e-04 | 42 | 331 | 5 | GO:0002438 | |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | RYR1 FGFR1 PLCB4 AKAP6 DRD2 ANK2 ATP13A1 CAMK2D CAV1 APP ATP2C1 P2RY6 P2RX2 SLC24A1 CDK5 PLCE1 | 5.92e-04 | 389 | 331 | 16 | GO:0055074 |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | GAD2 NR2F6 ERCC1 ACADVL SIK1 ZZEF1 CHRNA4 STAC CHRNA5 RYR1 CHRNB2 PER2 FGFR2 WNK3 CPEB2 DPP4 HSPG2 CACNB3 DRD2 LIMD1 RBM4B RBM4 CAMK2D CAMK2G PCARE XPC CAV1 CHORDC1 APP CR1 CR1L TG P2RX2 CPEB4 SLC24A1 CDH2 KDM1A CDK5 | 6.28e-04 | 1361 | 331 | 38 | GO:0009628 |
| GeneOntologyBiologicalProcess | response to oxygen levels | GAD2 CHRNA4 RYR1 CHRNB2 FGFR2 CPEB2 DPP4 HSPG2 DRD2 LIMD1 CAMK2D CAMK2G CAV1 CR1 CR1L P2RX2 CPEB4 | 6.29e-04 | 430 | 331 | 17 | GO:0070482 |
| GeneOntologyBiologicalProcess | hypersensitivity | 6.31e-04 | 25 | 331 | 4 | GO:0002524 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | STAC RYR1 TRPM5 PLCB4 AKAP6 CACNB3 DRD2 ANK2 CAMK2D FBXO11 CAV1 ATP2C1 P2RY6 P2RX2 SLC24A1 PLCE1 | 6.43e-04 | 392 | 331 | 16 | GO:0070588 |
| GeneOntologyBiologicalProcess | immune response-regulating cell surface receptor signaling pathway | CYLD USP9X OSCAR FYB2 CACNB3 CR1 NMI IGHG1 IGHG2 IGHG3 IGHG4 PAK3 IGLC1 IGLC3 CTLA4 IGLC6 | 6.61e-04 | 393 | 331 | 16 | GO:0002768 |
| GeneOntologyBiologicalProcess | immune response-activating signaling pathway | CYLD USP9X NAIP FYB2 CACNB3 CAV1 ALPK1 APP CR1 PPP2CA NMI IGHG1 IGHG2 IGHG3 IGHG4 PAK3 IGLC1 IGLC3 CTLA4 IGLC6 | 6.63e-04 | 553 | 331 | 20 | GO:0002757 |
| GeneOntologyBiologicalProcess | synaptic transmission, cholinergic | 6.71e-04 | 44 | 331 | 5 | GO:0007271 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | CHRNA3 CHRNA4 CHRNA5 CHRNB2 CHRNA6 CACNB3 DRD2 APP P2RX2 CDK5 | 6.82e-04 | 180 | 331 | 10 | GO:0060078 |
| GeneOntologyBiologicalProcess | negative regulation of small molecule metabolic process | 6.92e-04 | 149 | 331 | 9 | GO:0062014 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transporter activity | 7.02e-04 | 92 | 331 | 7 | GO:1901019 | |
| GeneOntologyBiologicalProcess | presynaptic modulation of chemical synaptic transmission | 7.15e-04 | 67 | 331 | 6 | GO:0099171 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 7.37e-04 | 26 | 331 | 4 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 7.37e-04 | 26 | 331 | 4 | GO:0006063 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | RYR1 PLCB4 AKAP6 DRD2 ANK2 ATP13A1 CAMK2D CAV1 APP ATP2C1 P2RY6 P2RX2 SLC24A1 CDK5 PLCE1 | 7.43e-04 | 359 | 331 | 15 | GO:0006874 |
| GeneOntologyBiologicalProcess | immune response-activating cell surface receptor signaling pathway | CYLD USP9X FYB2 CACNB3 CR1 NMI IGHG1 IGHG2 IGHG3 IGHG4 PAK3 IGLC1 IGLC3 CTLA4 IGLC6 | 7.43e-04 | 359 | 331 | 15 | GO:0002429 |
| GeneOntologyBiologicalProcess | lysosomal transport | 7.61e-04 | 151 | 331 | 9 | GO:0007041 | |
| GeneOntologyBiologicalProcess | synaptic transmission involved in micturition | 7.62e-04 | 3 | 331 | 2 | GO:0060084 | |
| GeneOntologyBiologicalProcess | ventricular zone neuroblast division | 7.62e-04 | 3 | 331 | 2 | GO:0021847 | |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic translational elongation | 7.62e-04 | 3 | 331 | 2 | GO:1900247 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | HSP90B2P DHRS3 UGT2B10 DPP4 UGT1A10 UGT1A8 UGT1A7 TIPARP CHST8 TG PCSK6 FSHB DKK3 | 7.70e-04 | 286 | 331 | 13 | GO:0042445 |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 8.09e-04 | 12 | 331 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | postsynaptic signal transduction | 8.37e-04 | 69 | 331 | 6 | GO:0098926 | |
| GeneOntologyBiologicalProcess | regulation of acute inflammatory response to antigenic stimulus | 8.54e-04 | 27 | 331 | 4 | GO:0002864 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport | 8.76e-04 | 154 | 331 | 9 | GO:0051928 | |
| GeneOntologyBiologicalProcess | vacuolar transport | FHIP1B PIK3C3 TGFBRAP1 VPS8 IGF2R IGHG1 IGHG2 IGHG3 IGHG4 M6PR | 9.14e-04 | 187 | 331 | 10 | GO:0007034 |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transporter activity | TCAF1 STAC SCN4B WNK3 AKAP6 CACNB3 DRD2 ANK2 CAMK2D CAV1 TMEM168 P2RY6 | 9.33e-04 | 256 | 331 | 12 | GO:0032412 |
| GeneOntologyBiologicalProcess | positive regulation of ion transmembrane transporter activity | 9.62e-04 | 97 | 331 | 7 | GO:0032414 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC6A19 SLC18B1 STAC RYR1 TRPM5 SLC5A6 SCN4B KCNJ16 PLCB4 WNK3 AKAP6 CACNB3 DRD2 ANK2 ATP13A1 CAMK2D FBXO11 CAV1 SLC25A22 SLC6A11 ATP2C1 TMEM168 SLC15A1 P2RY6 P2RX2 SLC18A2 SLC24A1 PLCE1 | 9.72e-04 | 922 | 331 | 28 | GO:0098662 |
| GeneOntologyCellularComponent | IgG immunoglobulin complex | 1.05e-13 | 14 | 331 | 9 | GO:0071735 | |
| GeneOntologyCellularComponent | dopaminergic synapse | 3.26e-08 | 22 | 331 | 7 | GO:0098691 | |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 6.99e-06 | 18 | 331 | 5 | GO:0005892 | |
| GeneOntologyCellularComponent | cell surface | AIMP1 CD109 OSCAR ZZEF1 CHRNA4 CHRNB2 CFHR4 PROM1 MFGE8 FGFR2 NCR1 PLXNB3 SEMA6C CCR10 DPP4 GPR37 SLITRK3 CAV1 APP CR1 CR1L GSR IGF2R TIMP2 P2RX2 IGHG1 IGHG2 IGHG3 IGHG4 PCSK6 CUZD1 CTLA4 SLC24A1 CDH2 IL6R CXCR2 | 3.85e-05 | 1111 | 331 | 36 | GO:0009986 |
| GeneOntologyCellularComponent | IgD immunoglobulin complex | 7.60e-05 | 6 | 331 | 3 | GO:0071738 | |
| GeneOntologyCellularComponent | IgE immunoglobulin complex | 7.60e-05 | 6 | 331 | 3 | GO:0071742 | |
| GeneOntologyCellularComponent | immunoglobulin complex, circulating | 1.25e-04 | 17 | 331 | 4 | GO:0042571 | |
| GeneOntologyCellularComponent | T-tubule | 2.56e-04 | 79 | 331 | 7 | GO:0030315 | |
| GeneOntologyCellularComponent | cholinergic synapse | 3.60e-04 | 22 | 331 | 4 | GO:0098981 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | ABCC3 EPPK1 NAIP SLC29A2 SLC5A6 KCNJ16 ANK2 CAV1 CR1 CR1L SLCO1B1 CASK P2RY6 CDH2 | 6.25e-04 | 320 | 331 | 14 | GO:0016323 |
| GeneOntologyCellularComponent | secretory granule membrane | CD109 SIGLEC5 SLC18B1 MFGE8 ATP8B3 SLC44A2 SIGLEC14 CAV1 CR1 IGF2R SLC18A2 CUZD1 VPS13B CXCR2 | 8.18e-04 | 329 | 331 | 14 | GO:0030667 |
| GeneOntologyCellularComponent | anchoring junction | CDH26 EPPK1 RPLP0 GJD4 ABCB4 JAK2 UBA1 ARHGAP31 AJM1 NECTIN1 SCN4B C1QTNF5 WNK3 TNS3 AKAP6 DPP4 HSPG2 FLNB FLNC ANK2 LIMD1 CAMK2D CAV1 APP CASK CDH24 IGF2R CDH2 PCDHGC3 | 9.03e-04 | 976 | 331 | 29 | GO:0070161 |
| GeneOntologyCellularComponent | sarcolemma | 9.33e-04 | 190 | 331 | 10 | GO:0042383 | |
| MousePheno | absent memory B cells | 1.36e-07 | 4 | 270 | 4 | MP:0008094 | |
| MousePheno | abnormal gluconeogenesis | 8.42e-06 | 54 | 270 | 8 | MP:0003383 | |
| MousePheno | decreased body temperature | 9.93e-06 | 91 | 270 | 10 | MP:0005534 | |
| MousePheno | decreased memory B cell number | 1.59e-05 | 9 | 270 | 4 | MP:0008729 | |
| MousePheno | decreased IgG2c level | 4.04e-05 | 11 | 270 | 4 | MP:0008897 | |
| MousePheno | abnormal memory B cell number | 4.04e-05 | 11 | 270 | 4 | MP:0008093 | |
| MousePheno | decreased circulating enzyme level | WWOX FTSJ1 TM6SF2 FHIP1B PHEX PIK3C3 LIMD1 CHD9 LDHA SLCO1B1 NMI TYW1B PHF14 TYW1 SYTL1 VPS13B | 5.32e-05 | 263 | 270 | 16 | MP:0014451 |
| MousePheno | decreased circulating alkaline phosphatase level | 5.68e-05 | 111 | 270 | 10 | MP:0002966 | |
| MousePheno | abnormal body temperature | CHRNA4 RYR1 FAAH FLNC DRD2 CAV1 SLC18A2 IGHG1 IGHG2 IGHG3 IGHG4 | 7.02e-05 | 137 | 270 | 11 | MP:0005535 |
| MousePheno | abnormal IgG2b level | 7.13e-05 | 114 | 270 | 10 | MP:0020177 | |
| MousePheno | abnormal memory B cell morphology | 1.17e-04 | 14 | 270 | 4 | MP:0002440 | |
| MousePheno | decreased enzyme/conezyme level | WWOX FTSJ1 TM6SF2 FHIP1B PHEX PIK3C3 LIMD1 CHD9 LDHA SLCO1B1 NMI TYW1B PHF14 TYW1 SYTL1 VPS13B | 1.31e-04 | 284 | 270 | 16 | MP:0014449 |
| MousePheno | abnormal sternum morphology | FHIP1B PGAP1 FGFR1 FGFR2 HSPG2 FLNB FRAS1 SMCHD1 PPAT TIPARP WDR19 IGF2R TENM4 ADAMTS6 HPS6 | 1.32e-04 | 255 | 270 | 15 | MP:0000157 |
| MousePheno | abnormal chondrocyte physiology | 1.44e-04 | 42 | 270 | 6 | MP:0009780 | |
| MousePheno | abnormal plasma cell differentiation | 1.57e-04 | 15 | 270 | 4 | MP:0008099 | |
| MousePheno | abnormal cartilage physiology | 1.64e-04 | 43 | 270 | 6 | MP:0031306 | |
| Domain | Nicotinic_acetylcholine_rcpt | 6.04e-06 | 16 | 328 | 5 | IPR002394 | |
| Domain | Ig/MHC_CS | 7.42e-06 | 58 | 328 | 8 | IPR003006 | |
| Domain | IG_MHC | 9.60e-06 | 60 | 328 | 8 | PS00290 | |
| Domain | IG_LIKE | MYBPH PRTG IGSF6 OSCAR SIGLEC5 HEPACAM2 IGLL5 NECTIN1 SCN4B FGFR1 FGFR2 NCR1 HSPG2 ADAMTSL1 SIGLEC14 IGHG1 IGHG2 IGHG3 IGHG4 HAPLN3 IGLC3 CTLA4 IL6R | 2.09e-05 | 491 | 328 | 23 | PS50835 |
| Domain | CEBP_ZZ | 2.12e-05 | 4 | 328 | 3 | PF16366 | |
| Domain | RRM_7 | 2.12e-05 | 4 | 328 | 3 | PF16367 | |
| Domain | CEBP_ZZ | 2.12e-05 | 4 | 328 | 3 | IPR032296 | |
| Domain | Ig-like_dom | MYBPH PRTG IGSF6 OSCAR SIGLEC5 HEPACAM2 IGLL5 NECTIN1 SCN4B FGFR1 FGFR2 NCR1 HSPG2 ADAMTSL1 SIGLEC14 IGHG1 IGHG2 IGHG3 IGHG4 HAPLN3 IGLC3 CTLA4 IL6R | 3.05e-05 | 503 | 328 | 23 | IPR007110 |
| Domain | - | 4.20e-05 | 23 | 328 | 5 | 1.20.120.370 | |
| Domain | Acetylcholine_rcpt_TM | 4.20e-05 | 23 | 328 | 5 | IPR027361 | |
| Domain | Ig-like_fold | MYBPH EPHB3 PRTG IGSF6 OSCAR SIGLEC5 HEPACAM2 IGLL5 NECTIN1 SCN4B FGFR1 FGFR2 NCR1 PLXNB3 TRIM46 HSPG2 FLNB FLNC ADAMTSL1 SIGLEC14 IGHG1 IGHG2 IGHG3 IGHG4 HAPLN3 IGLC3 CTLA4 IL6R | 5.45e-05 | 706 | 328 | 28 | IPR013783 |
| Domain | PLAC | 8.13e-05 | 14 | 328 | 4 | PF08686 | |
| Domain | PLAC | 2.94e-04 | 19 | 328 | 4 | PS50900 | |
| Domain | PLAC | 2.94e-04 | 19 | 328 | 4 | IPR010909 | |
| Domain | Ketoacyl-synt_C | 3.07e-04 | 2 | 328 | 2 | PF02801 | |
| Domain | Acyl_transf_1 | 3.07e-04 | 2 | 328 | 2 | PF00698 | |
| Domain | GPR37_orph | 3.07e-04 | 2 | 328 | 2 | IPR003909 | |
| Domain | PKS_KS | 3.07e-04 | 2 | 328 | 2 | SM00825 | |
| Domain | PKS_AT | 3.07e-04 | 2 | 328 | 2 | SM00827 | |
| Domain | B_KETOACYL_SYNTHASE | 3.07e-04 | 2 | 328 | 2 | PS00606 | |
| Domain | Ketoacyl_synth_AS | 3.07e-04 | 2 | 328 | 2 | IPR018201 | |
| Domain | Malonyl_transacylase_ACP-bd | 3.07e-04 | 2 | 328 | 2 | IPR016036 | |
| Domain | Wyosine_form | 3.07e-04 | 2 | 328 | 2 | PF08608 | |
| Domain | - | 3.07e-04 | 2 | 328 | 2 | 3.40.366.10 | |
| Domain | Ac_transferase_dom | 3.07e-04 | 2 | 328 | 2 | IPR001227 | |
| Domain | PKS_Beta-ketoAc_synthase_dom | 3.07e-04 | 2 | 328 | 2 | IPR020841 | |
| Domain | PKS_acyl_transferase | 3.07e-04 | 2 | 328 | 2 | IPR020801 | |
| Domain | ketoacyl-synt | 3.07e-04 | 2 | 328 | 2 | PF00109 | |
| Domain | tRNA_wybutosine-synth | 3.07e-04 | 2 | 328 | 2 | IPR013917 | |
| Domain | Acyl_transferase | 3.07e-04 | 2 | 328 | 2 | IPR014043 | |
| Domain | Ketoacyl_synth_N | 3.07e-04 | 2 | 328 | 2 | IPR014030 | |
| Domain | Ketoacyl_synth_C | 3.07e-04 | 2 | 328 | 2 | IPR014031 | |
| Domain | UPF0012 | 3.07e-04 | 2 | 328 | 2 | PS01227 | |
| Domain | C1-set | 3.56e-04 | 54 | 328 | 6 | PF07654 | |
| Domain | IGc1 | 4.35e-04 | 56 | 328 | 6 | SM00407 | |
| Domain | UDPGT | 4.41e-04 | 21 | 328 | 4 | PF00201 | |
| Domain | UDP_glucos_trans | 4.41e-04 | 21 | 328 | 4 | IPR002213 | |
| Domain | UDPGT | 4.41e-04 | 21 | 328 | 4 | PS00375 | |
| Domain | CUB_dom | 4.79e-04 | 57 | 328 | 6 | IPR000859 | |
| Domain | Ig_C1-set | 5.26e-04 | 58 | 328 | 6 | IPR003597 | |
| Domain | Neurotransmitter_ion_chnl_CS | 1.11e-03 | 45 | 328 | 5 | IPR018000 | |
| Domain | Neur_chan_memb | 1.23e-03 | 46 | 328 | 5 | PF02932 | |
| Domain | IG | MYBPH PRTG IGSF6 OSCAR SIGLEC5 HEPACAM2 NECTIN1 SCN4B FGFR1 FGFR2 NCR1 HSPG2 ADAMTSL1 SIGLEC14 HAPLN3 CTLA4 IL6R | 1.32e-03 | 421 | 328 | 17 | SM00409 |
| Domain | Ig_sub | MYBPH PRTG IGSF6 OSCAR SIGLEC5 HEPACAM2 NECTIN1 SCN4B FGFR1 FGFR2 NCR1 HSPG2 ADAMTSL1 SIGLEC14 HAPLN3 CTLA4 IL6R | 1.32e-03 | 421 | 328 | 17 | IPR003599 |
| Domain | Neur_chan_LBD | 1.36e-03 | 47 | 328 | 5 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 1.36e-03 | 47 | 328 | 5 | PS00236 | |
| Domain | Neur_channel | 1.36e-03 | 47 | 328 | 5 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 1.36e-03 | 47 | 328 | 5 | IPR006202 | |
| Domain | Neurotrans-gated_channel_TM | 1.36e-03 | 47 | 328 | 5 | IPR006029 | |
| Domain | - | 1.36e-03 | 47 | 328 | 5 | 2.70.170.10 | |
| Domain | B30.2/SPRY | 1.43e-03 | 95 | 328 | 7 | IPR001870 | |
| Domain | B302_SPRY | 1.43e-03 | 95 | 328 | 7 | PS50188 | |
| Domain | - | MYBPH EPHB3 PRTG IGSF6 OSCAR SIGLEC5 HEPACAM2 IGLL5 NECTIN1 SCN4B FGFR1 FGFR2 NCR1 PLXNB3 TRIM46 HSPG2 FLNB FLNC ADAMTSL1 SIGLEC14 HAPLN3 CTLA4 IL6R | 1.57e-03 | 663 | 328 | 23 | 2.60.40.10 |
| Domain | CUB | 1.64e-03 | 49 | 328 | 5 | PF00431 | |
| Domain | ATPase_dyneun-rel_AAA | 1.69e-03 | 14 | 328 | 3 | IPR011704 | |
| Domain | MT | 1.69e-03 | 14 | 328 | 3 | PF12777 | |
| Domain | AAA_8 | 1.69e-03 | 14 | 328 | 3 | PF12780 | |
| Domain | AAA_5 | 1.69e-03 | 14 | 328 | 3 | PF07728 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.69e-03 | 14 | 328 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.69e-03 | 14 | 328 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.69e-03 | 14 | 328 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.69e-03 | 14 | 328 | 3 | PF08393 | |
| Domain | CUB | 1.80e-03 | 50 | 328 | 5 | SM00042 | |
| Domain | DUF1908 | 1.80e-03 | 4 | 328 | 2 | PF08926 | |
| Domain | MAST_pre-PK_dom | 1.80e-03 | 4 | 328 | 2 | IPR023142 | |
| Domain | CaMKII_AD | 1.80e-03 | 4 | 328 | 2 | PF08332 | |
| Domain | RetinoicA-induced_16-like | 1.80e-03 | 4 | 328 | 2 | IPR019384 | |
| Domain | RAI16-like | 1.80e-03 | 4 | 328 | 2 | PF10257 | |
| Domain | MA_Ser/Thr_Kinase_dom | 1.80e-03 | 4 | 328 | 2 | IPR015022 | |
| Domain | Ca/CaM-dep_prot_kinase-assoc | 1.80e-03 | 4 | 328 | 2 | IPR013543 | |
| Domain | FGF_rcpt_fam | 1.80e-03 | 4 | 328 | 2 | IPR016248 | |
| Domain | - | 1.80e-03 | 4 | 328 | 2 | 1.20.1480.20 | |
| Pathway | WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS | 1.65e-09 | 21 | 254 | 8 | M39343 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 2.17e-07 | 9 | 254 | 5 | M27597 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 2.17e-07 | 9 | 254 | 5 | MM15313 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 7.72e-07 | 11 | 254 | 5 | M883 | |
| Pathway | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.30e-06 | 12 | 254 | 5 | M48008 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.30e-06 | 12 | 254 | 5 | MM15312 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 3.20e-06 | 14 | 254 | 5 | M757 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 4.73e-06 | 15 | 254 | 5 | MM14704 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 5.34e-06 | 39 | 254 | 7 | MM15695 | |
| Pathway | REACTOME_DRUG_ADME | NAT2 ABCC3 SLC29A2 GGT7 ADK UGT2B10 UGT1A10 UGT1A8 UGT1A7 SLCO1B1 | 2.70e-05 | 109 | 254 | 10 | M45012 |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NICOTINE_TO_JAK_STAT_SIGNALING_PATHWAY | 5.63e-05 | 5 | 254 | 3 | M48978 | |
| Pathway | REACTOME_DRUG_ADME | NAT2 ABCC3 SLC29A2 GGT7 ADK UGT2B10 UGT1A10 UGT1A8 UGT1A7 SLCO1B1 | 5.75e-05 | 119 | 254 | 10 | MM15692 |
| Pathway | REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION | 6.39e-05 | 39 | 254 | 6 | MM17212 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 8.94e-05 | 14 | 254 | 4 | M39328 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | GAD2 CHRNA3 CHRNA4 CHRNA5 CHRNB2 KCNJ16 CHRNA6 CACNB3 CAMK2D CAMK2G CASK SLC6A11 SLC18A2 | 1.19e-04 | 211 | 254 | 13 | MM14502 |
| Pathway | REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS | 1.92e-04 | 7 | 254 | 3 | M27596 | |
| Pathway | REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS | 1.92e-04 | 7 | 254 | 3 | MM15311 | |
| Pathway | REACTOME_PP2A_MEDIATED_DEPHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS | 1.92e-04 | 7 | 254 | 3 | M26992 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 2.10e-04 | 48 | 254 | 6 | MM17214 | |
| Pathway | BIOCARTA_P35ALZHEIMERS_PATHWAY | 3.03e-04 | 8 | 254 | 3 | M12718 | |
| Pathway | REACTOME_RAF_ACTIVATION | 3.31e-04 | 34 | 254 | 5 | M27556 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCC3 CAND1 SLC6A19 SLC29A2 RYR1 ABCB4 TRPM5 PSME4 SLC5A6 WNK3 PLEKHA8 ATP8B3 ATP13A1 CAMK2D CAMK2G SLC44A2 SLCO1B1 SLC25A22 SLC6A11 ATP2C1 SLC15A1 SLC45A3 SLC18A2 SLC25A1 PCSK6 SLC24A1 SLC2A11 | 3.57e-04 | 736 | 254 | 27 | M27287 |
| Pathway | REACTOME_RAF_ACTIVATION | 3.81e-04 | 35 | 254 | 5 | MM15271 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 4.04e-04 | 54 | 254 | 6 | MM14655 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_ACTIVITY_OF_TFAP2_AP_2_FAMILY_TRANSCRIPTION_FACTORS | 4.48e-04 | 9 | 254 | 3 | MM15509 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 4.93e-04 | 56 | 254 | 6 | MM14815 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCC3 CAND1 SLC6A19 SLC29A2 RYR1 ABCB4 TRPM5 PSME4 SLC5A6 PLEKHA8 ATP8B3 ATP13A1 CAMK2D CAMK2G SLC44A2 SLCO1B1 SLC25A22 SLC6A11 ATP2C1 SLC15A1 SLC45A3 SLC18A2 SLC25A1 PCSK6 SLC24A1 | 5.88e-04 | 681 | 254 | 25 | MM14985 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC6A19 SLC29A2 SLC5A6 SLC44A2 SLCO1B1 SLC25A22 SLC6A11 SLC15A1 SLC45A3 SLC18A2 SLC25A1 SLC24A1 SLC2A11 | 5.94e-04 | 249 | 254 | 13 | M5988 |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_ACTIVITY_OF_TFAP2_AP_2_FAMILY_TRANSCRIPTION_FACTORS | 6.32e-04 | 10 | 254 | 3 | M27764 | |
| Pathway | REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1 | 6.32e-04 | 10 | 254 | 3 | MM14509 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 6.37e-04 | 39 | 254 | 5 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 6.37e-04 | 39 | 254 | 5 | MM15165 | |
| Pubmed | 4.44e-13 | 15 | 338 | 8 | 20176268 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CDH26 CAND1 WWOX WDR4 DHRS3 ERV3-1 AIMP1 NAIP PFKFB1 NIT2 JAK2 PHKB TBC1D4 PIK3C3 SUPT6H TGFBRAP1 PLCB4 SNX9 RECK FLNB CACNB3 LIMD1 RBM4 RALGAPB MACROD1 ADGRL1 CHD9 G2E3 SLITRK3 APP CASK DNAH1 KLK4 ATP2C1 TIMP2 XPNPEP3 NAXD KNDC1 MAST1 PAK3 PHF14 CSMD1 SYTL1 VPS13B IL6R SLC2A11 | 4.88e-12 | 1489 | 338 | 46 | 28611215 |
| Pubmed | ABCC3 CAND1 WWOX USP9X ETFA UNC13D POLA2 HDAC3 MFGE8 FASN UBA1 NIT1 OXSM PGP ATP13A1 CAMK2G RALGAPB MACROD1 YRDC FBXO11 ERI1 PPAT PAPSS1 TFAP2C GSR STT3B DHX30 PPP2CA SETD2 NOP58 CDK5RAP3 ATP2C1 SLC25A1 XPNPEP3 PHF14 DEPDC5 SCAI CXCR2 CDK5 | 9.82e-10 | 1327 | 338 | 39 | 32694731 | |
| Pubmed | Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesis. | 1.74e-09 | 7 | 338 | 5 | 30538335 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SDSL ABCC3 NR2F6 EPPK1 TMCO6 FHIP1B ZZEF1 SLC29A2 RYR1 GGT7 JAK2 TDRD3 FASN PSME4 PER2 FGFR1 FGFR2 HERC1 SEMA6C HSPG2 FLNC FRAS1 ATP13A1 ADGRL1 DHX30 SLC25A22 PPP2CB IGF2R SLC45A3 NISCH HPS6 TXNRD3 DEPDC5 MAPKBP1 | 4.06e-09 | 1105 | 338 | 34 | 35748872 |
| Pubmed | Functional interaction between Lypd6 and nicotinic acetylcholine receptors. | 4.60e-09 | 8 | 338 | 5 | 27344019 | |
| Pubmed | Highly specific anti-estradiol antibodies: structural characterisation and binding diversity. | 8.76e-09 | 4 | 338 | 4 | 11812141 | |
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 6794027 | ||
| Pubmed | Further evidence that BALB/c and C57BL/6 gamma 2a genes originate from two distinct isotypes. | 8.76e-09 | 4 | 338 | 4 | 2510996 | |
| Pubmed | Sialic acid residues are essential for the anaphylactic activity of murine IgG1 antibodies. | 8.76e-09 | 4 | 338 | 4 | 19050247 | |
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 7892607 | ||
| Pubmed | Shutdown of class switch recombination by deletion of a switch region control element. | 8.76e-09 | 4 | 338 | 4 | 8438159 | |
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 4098598 | ||
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 6253932 | ||
| Pubmed | Immunoglobulin gamma 1 heavy chain gene: structural gene sequences cloned in a bacterial plasmid. | 8.76e-09 | 4 | 338 | 4 | 6769752 | |
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 1542303 | ||
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 9725203 | ||
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 4831970 | ||
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 12209645 | ||
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 116231 | ||
| Pubmed | Nucleotide sequences of gene segments encoding membrane domains of immunoglobulin gamma chains. | 8.76e-09 | 4 | 338 | 4 | 6283537 | |
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 6777755 | ||
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 6297797 | ||
| Pubmed | Evolution of immunoglobulin subclasses. Primary structure of a murine myeloma gamma1 chain. | 8.76e-09 | 4 | 338 | 4 | 98524 | |
| Pubmed | Gene segments encoding transmembrane carboxyl termini of immunoglobulin gamma chains. | 8.76e-09 | 4 | 338 | 4 | 6799207 | |
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 6787604 | ||
| Pubmed | Rearrangement of immunoglobulin gamma 1-chain gene and mechanism for heavy-chain class switch. | 8.76e-09 | 4 | 338 | 4 | 6767246 | |
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 12051834 | ||
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 8683112 | ||
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 6804950 | ||
| Pubmed | Integrin-dependent organization and bidirectional vesicular traffic at cytotoxic immune synapses. | 8.76e-09 | 4 | 338 | 4 | 19592272 | |
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 10720538 | ||
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 15699144 | ||
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 2513486 | ||
| Pubmed | Independent immunoglobulin class-switch events occurring in a single myeloma cell line. | 8.76e-09 | 4 | 338 | 4 | 3921826 | |
| Pubmed | Sequence analysis of cloned cDNA encoding part of an immunoglobulin heavy chain. | 8.76e-09 | 4 | 338 | 4 | 113776 | |
| Pubmed | Spontaneous deletions in Ig heavy chain genes: flanking sequences influence splice site selection. | 8.76e-09 | 4 | 338 | 4 | 1754385 | |
| Pubmed | An autoimmune disease variant of IgG1 modulates B cell activation and differentiation. | 8.76e-09 | 4 | 338 | 4 | 30287618 | |
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 4565406 | ||
| Pubmed | IgG1 protects against renal disease in a mouse model of cryoglobulinaemia. | 8.76e-09 | 4 | 338 | 4 | 25363774 | |
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 20621099 | ||
| Pubmed | Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98). | 8.76e-09 | 4 | 338 | 4 | 12414967 | |
| Pubmed | Mouse immunoglobulin allotypes: post-duplication divergence of gamma 2a and gamma 2b chain genes. | 8.76e-09 | 4 | 338 | 4 | 6803173 | |
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 6264445 | ||
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 2878362 | ||
| Pubmed | IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB/c mice. | 8.76e-09 | 4 | 338 | 4 | 25867470 | |
| Pubmed | Nucleotide sequences of all the gamma gene loci of murine immunoglobulin heavy chains. | 8.76e-09 | 4 | 338 | 4 | 9126488 | |
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 8452816 | ||
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 7439686 | ||
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 6278424 | ||
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 35133976 | ||
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 8099342 | ||
| Pubmed | Ubiquitination of IgG1 cytoplasmic tail modulates B-cell signalling and activation. | 8.76e-09 | 4 | 338 | 4 | 32006024 | |
| Pubmed | Sequence of the cloned gene for the constant region of murine gamma 2b immunoglobulin heavy chain. | 8.76e-09 | 4 | 338 | 4 | 117549 | |
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 25451975 | ||
| Pubmed | Somatic mutation in genes for the variable portion of the immunoglobulin heavy chain. | 8.76e-09 | 4 | 338 | 4 | 6801765 | |
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 6306571 | ||
| Pubmed | Selectivity of ABT-089 for alpha4beta2* and alpha6beta2* nicotinic acetylcholine receptors in brain. | 8.76e-09 | 4 | 338 | 4 | 19481067 | |
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 1672339 | ||
| Pubmed | Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. | 8.76e-09 | 4 | 338 | 4 | 1713710 | |
| Pubmed | The roles of gamma 1 heavy chain membrane expression and cytoplasmic tail in IgG1 responses. | 8.76e-09 | 4 | 338 | 4 | 9103199 | |
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 38268239 | ||
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 6170065 | ||
| Pubmed | Distinction of the memory B cell response to cognate antigen versus bystander inflammatory signals. | 8.76e-09 | 4 | 338 | 4 | 19703988 | |
| Pubmed | Genes for immunoglobulin heavy chain and serum prealbumin protein are linked in mouse. | 8.76e-09 | 4 | 338 | 4 | 807855 | |
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 4166666 | ||
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 26201558 | ||
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 6249338 | ||
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 24752300 | ||
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 26801076 | ||
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 36763580 | ||
| Pubmed | 8.76e-09 | 4 | 338 | 4 | 6262729 | ||
| Pubmed | Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid. | 8.76e-09 | 4 | 338 | 4 | 26683050 | |
| Pubmed | Complete nucleotide sequence of immunoglobulin gamma2b chain gene cloned from newborn nouse DNA. | 8.76e-09 | 4 | 338 | 4 | 6766534 | |
| Pubmed | 1.03e-08 | 9 | 338 | 5 | 8906617 | ||
| Pubmed | 2.04e-08 | 10 | 338 | 5 | 31042473 | ||
| Pubmed | 2.04e-08 | 10 | 338 | 5 | 20736995 | ||
| Pubmed | THSD4 ABCC3 CD109 RYR1 MFGE8 FASN DNAH5 HSPG2 FLNC MRPL39 IGHG1 IGHG2 IGHG3 IGHG4 | 2.81e-08 | 214 | 338 | 14 | 22199357 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPRS1 CPNE8 EPPK1 CAND1 RPLP0 IRF2BP1 ACADVL USP9X ETFA WDR3 FASN UBA1 SUPT6H HEATR5B SNX9 FLNB FLNC RBM4B RBM4 SMCHD1 SEC22B APP LDHA DHX30 NOP58 IGF2R IGHG1 XPNPEP3 IGLC1 HADHA KDM1A | 2.95e-08 | 1024 | 338 | 31 | 24711643 |
| Pubmed | Nicotinic Cholinergic Receptors in VTA Glutamate Neurons Modulate Excitatory Transmission. | 3.71e-08 | 11 | 338 | 5 | 29791835 | |
| Pubmed | 3.71e-08 | 11 | 338 | 5 | 12225896 | ||
| Pubmed | Exon shuffling generates an immunoglobulin heavy chain gene. | 4.35e-08 | 5 | 338 | 4 | 6769120 | |
| Pubmed | Chromosomal location of the structural gene cluster encoding murine immunoglobulin heavy chains. | 4.35e-08 | 5 | 338 | 4 | 6770027 | |
| Pubmed | A novel allele for inducible Cre expression in germinal center BÂ cells. | 4.35e-08 | 5 | 338 | 4 | 30359469 | |
| Pubmed | 4.35e-08 | 5 | 338 | 4 | 23423996 | ||
| Pubmed | 4.35e-08 | 5 | 338 | 4 | 32229726 | ||
| Pubmed | 4.35e-08 | 5 | 338 | 4 | 33025844 | ||
| Pubmed | Low ethanol concentration alters CHRNA5 RNA levels during early human development. | 4.35e-08 | 5 | 338 | 4 | 20438829 | |
| Pubmed | 4.35e-08 | 5 | 338 | 4 | 27167731 | ||
| Pubmed | Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16). | 4.35e-08 | 5 | 338 | 4 | 9743367 | |
| Pubmed | Cre-loxP-mediated gene replacement: a mouse strain producing humanized antibodies. | 4.35e-08 | 5 | 338 | 4 | 7704573 | |
| Pubmed | Channel catfish soluble FcmuR binds conserved linear epitopes present on Cmu3 and Cmu4. | 4.35e-08 | 5 | 338 | 4 | 20031218 | |
| Pubmed | 4.35e-08 | 5 | 338 | 4 | 9834201 | ||
| Pubmed | 4.35e-08 | 5 | 338 | 4 | 103631 | ||
| Pubmed | 4.35e-08 | 5 | 338 | 4 | 33163250 | ||
| Pubmed | 4.35e-08 | 5 | 338 | 4 | 37310381 | ||
| Pubmed | 4.35e-08 | 5 | 338 | 4 | 36853944 | ||
| Pubmed | The disulphide bridges of a mouse immunoglobulin G1 protein. | 4.35e-08 | 5 | 338 | 4 | 5073237 | |
| Pubmed | Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma. | 4.35e-08 | 5 | 338 | 4 | 35044826 | |
| Pubmed | Sequential class switching is required for the generation of high affinity IgE antibodies. | 4.35e-08 | 5 | 338 | 4 | 22249450 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 9.98e-07 | 16 | 220 | 5 | 173 | |
| GeneFamily | Solute carriers | SLC6A19 SLC29A2 SLC18B1 SLC5A6 SLC44A2 SLCO1B1 SLC7A14 SLC25A22 SLC6A11 SLC15A1 SLC45A3 SLC18A2 SLC25A1 SLC24A1 SLC2A11 SLC25A31 | 2.84e-05 | 395 | 220 | 16 | 752 |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | CD109 SIGLEC5 PROM1 NECTIN1 FGFR1 FGFR2 NCR1 DPP4 CR1 IGF2R CTLA4 CDH2 IL6R CXCR2 | 3.49e-04 | 394 | 220 | 14 | 471 |
| GeneFamily | UDP glucuronosyltransferases | 5.87e-04 | 32 | 220 | 4 | 363 | |
| GeneFamily | Ubiquitin specific peptidases | 5.88e-04 | 56 | 220 | 5 | 366 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 6.38e-04 | 57 | 220 | 5 | 1179 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 8.76e-04 | 163 | 220 | 8 | 590 | |
| GeneFamily | Dyneins, axonemal | 1.07e-03 | 17 | 220 | 3 | 536 | |
| GeneFamily | CD molecules|MRH domain containing | 2.14e-03 | 6 | 220 | 2 | 1233 | |
| GeneFamily | ADAMTS like | 2.97e-03 | 7 | 220 | 2 | 947 | |
| Coexpression | HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_7DY_UP | 1.92e-07 | 49 | 336 | 8 | M41093 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_CD4_TCELL_DN | IP6K1 NIT2 ADK MFGE8 UGT2B10 NIT1 HERC1 CPEB2 RBM4B XPC ATP2C1 TIMP2 CDH2 KIF1C | 3.42e-07 | 200 | 336 | 14 | M8847 |
| Coexpression | MANN_RESPONSE_TO_AMIFOSTINE_UP | 3.37e-06 | 19 | 336 | 5 | M18954 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_PLASMA_CELLS | 5.78e-06 | 21 | 336 | 5 | M39281 | |
| Coexpression | IKEDA_MIR30_TARGETS_DN | 1.17e-05 | 24 | 336 | 5 | MM932 | |
| Coexpression | IKEDA_MIR30_TARGETS_DN | 1.17e-05 | 24 | 336 | 5 | M2380 | |
| Coexpression | GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN | PGAP6 PANK1 FASN PSME4 TGFBRAP1 HPS4 SLC44A2 SETD2 NISCH DEPDC5 VPS13B | 2.36e-05 | 181 | 336 | 11 | M8662 |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000_k-means-cluster#5 | 9.64e-06 | 89 | 328 | 9 | Arv_SC-hpx_blastocyst_1000_K5 | |
| ToppCell | moderate-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | SIDT1 SIK1 USP9Y IGLL5 PHEX NECTIN1 CHST12 DPP4 FLNB APP PPP1R14B P2RY6 PHF14 | 1.34e-09 | 180 | 338 | 13 | 1d8df7df03a71f49d6683554d3c948ce90dda42e |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | THSD4 JAK2 MAST4 PSME4 DDX60L FHIP1A AKAP6 FLNC ANK2 CAMK2D CAV1 CPEB4 CDH2 | 2.60e-09 | 190 | 338 | 13 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b |
| ToppCell | normal_Lung-B_lymphocytes|normal_Lung / Location, Cell class and cell subclass | SIDT1 IGLL5 PHEX PPP1R14B P2RY6 IGHG1 IGHG2 IGHG3 IGHG4 IGLC2 IGLC3 IGLC6 | 1.34e-08 | 179 | 338 | 12 | 5b89193486100b6754c1c5eca3105ea955805eae |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | THSD4 JAK2 MAST4 PSME4 FHIP1A FYB2 AKAP6 FLNC ANK2 CAMK2D CPEB4 CDH2 | 2.46e-08 | 189 | 338 | 12 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 |
| ToppCell | ILEUM|World / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | IGLL5 CH25H FBXO11 CAV1 TIPARP IGHG1 IGHG2 IGHG3 IGHG4 IGLC2 IGLC3 CTLA4 | 2.61e-08 | 190 | 338 | 12 | 4395dbd18c14d491f5066a2ddac438a16b1fd7c3 |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | THSD4 PEBP4 TBC1D4 MAST4 FHIP1A FYB2 AKAP6 ANK2 SGCG FRY CPEB4 CDH2 | 2.93e-08 | 192 | 338 | 12 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-Tregs|GI_small-bowel / Manually curated celltypes from each tissue | CD109 PLPPR1 STAC PHEX TBC1D4 FGFR2 CHRNA6 FLNC CTLA4 PAX9 IL6R | 3.45e-08 | 157 | 338 | 11 | c44bd530e396b08f16f284e185dcb830843959ea |
| ToppCell | Epithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | ABCC3 TCAF1 UNC13D TNS3 HSPG2 CAV1 PAPSS1 TIMP2 LGALS13 CDH2 DKK3 SCAI | 4.12e-08 | 198 | 338 | 12 | fbc46b20bcd44f2083170aacbc6f5dd00fba685c |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | MAST4 NOVA2 HSPG2 FLNB CAV1 CDH24 ADAMTS6 IGHG1 IGHG3 IGHG4 IGLC2 IGLC3 | 4.61e-08 | 200 | 338 | 12 | 27507c4b41d45c7cc50e4993169c0302be22ee34 |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Endothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | MAST4 NOVA2 HSPG2 FLNB CAV1 CDH24 ADAMTS6 IGHG1 IGHG3 IGHG4 IGLC2 IGLC3 | 4.61e-08 | 200 | 338 | 12 | b65fb8d378abd91cdabf5faac5f4b90d527f8c44 |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | MAST4 NOVA2 HSPG2 FLNB CAV1 CDH24 ADAMTS6 IGHG1 IGHG3 IGHG4 IGLC2 IGLC3 | 4.61e-08 | 200 | 338 | 12 | 2cb6e35add34b9dc564ebcf5d3cbc761325ca9f4 |
| ToppCell | Club_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | EPHB3 HEPACAM2 PHEX PROM1 THSD7B IGHG1 IGHG3 IGHG4 IGLC2 IGLC3 PAX9 | 6.51e-08 | 167 | 338 | 11 | dbdaaeb3bd9139cb008d9fe24ec031fc5628f136 |
| ToppCell | Int-URO-Lymphocyte-B-B_intermediate|Int-URO / Disease, Lineage and Cell Type | IGLL5 PEBP4 ABCB4 ANK2 KLK4 IGHG1 IGHG2 IGHG3 IGHG4 IGLC2 IGLC3 | 6.92e-08 | 168 | 338 | 11 | 5b3fb1fc8fea810c6d4e6feb42c24fb57e8066de |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SIGLEC5 UNC13D FHIP1B TBC1D4 POLN TMPRSS7 CPEB2 FAT3 SLC18A2 SYTL1 CXCR2 | 9.33e-08 | 173 | 338 | 11 | 889a880de5fc19d26b82cfef3067869a28ef17ca |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SIGLEC5 UNC13D FHIP1B TBC1D4 POLN TMPRSS7 CPEB2 FAT3 SLC18A2 SYTL1 CXCR2 | 9.33e-08 | 173 | 338 | 11 | 53e97835d7a518c278e7b90a0734eb0095d6aa33 |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SDSL FAAH ADK TBC1D4 POLN TMPRSS7 FLNB ADAMTSL1 FAT3 SLC45A3 SLC18A2 | 1.40e-07 | 180 | 338 | 11 | 41e8155cc7b3dac9d496e4077845ca6af1591a5c |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SDSL FAAH ADK TBC1D4 AJM1 POLN TMPRSS7 FLNB ADAMTSL1 SLC45A3 SLC18A2 | 1.48e-07 | 181 | 338 | 11 | 382337427be3c11ecd03e9fa2c2e831a9674c6a7 |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | SIK1 ADK ANK2 CAMK2D KLK4 IGHG1 IGHG2 IGHG3 IGHG4 IGLC2 IGLC3 | 1.65e-07 | 183 | 338 | 11 | 01664fce6b70a02c9d39d747b6a6aabc86d57bc2 |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | THSD4 TBC1D4 MAST4 FYB2 AKAP6 FLNC ANK2 CAMK2D FRY CPEB4 CDH2 | 1.74e-07 | 184 | 338 | 11 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 |
| ToppCell | Control-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | SIK1 IGLL5 CCR10 IGHG1 IGHG2 IGHG3 IGHG4 CPEB4 IGLC2 IGLC3 IGLC6 | 1.94e-07 | 186 | 338 | 11 | a08a50bff4e629588faa22440d57334b1df0e8df |
| ToppCell | control-Lymphocytic-Plasmablast|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | HSP90B2P IGLL5 CCR10 CAV1 IGHG1 IGHG2 IGHG3 IGHG4 IGLC2 IGLC3 IGLC6 | 2.05e-07 | 187 | 338 | 11 | 94a44b31ce9fe6fb4758769018fb746e93c8f043 |
| ToppCell | Bac-SEP-Lymphocyte-B|Bac-SEP / Disease, Lineage and Cell Type | IGLL5 ABCB4 ADK CAV1 IGHG1 IGHG2 IGHG3 IGHG4 IGLC2 IGLC3 IGLC6 | 2.05e-07 | 187 | 338 | 11 | 027aa7b5be402fc82ae13c346dfb4c0c751a07e9 |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-naive_B_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | IGLL5 ABCB4 CAMK2D ADAMTS6 P2RX2 IGHG1 IGHG2 IGHG3 IGLC2 IGLC3 IGLC6 | 2.16e-07 | 188 | 338 | 11 | 31129152386e9aba16f749d78da12a08b916e6f8 |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | THSD4 PEBP4 TBC1D4 FYB2 AKAP6 ANK2 SGCG FRY CPEB4 HADHA CDH2 | 2.28e-07 | 189 | 338 | 11 | 9c1debd65c13d63fd4f3158917d621b44b714c26 |
| ToppCell | control-Lymphocytic-Plasmablast|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | HSP90B2P IGLL5 GMPPA CAV1 IGHG1 IGHG2 IGHG3 IGHG4 IGLC2 IGLC3 IGLC6 | 2.28e-07 | 189 | 338 | 11 | 2e4c2618d06120f83cb4887dd3497b81984a8607 |
| ToppCell | mild-Lymphocytic-Plasmablast|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | HSP90B2P IGLL5 GMPPA CCR10 CAV1 IGHG1 IGHG2 IGHG3 IGHG4 IGLC2 IGLC3 | 2.28e-07 | 189 | 338 | 11 | db2097e6e165004d47ed504e115083a4e4f4b147 |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | THSD4 PEBP4 TBC1D4 MAST4 FYB2 AKAP6 ANK2 SGCG CAMK2D CPEB4 CDH2 | 2.41e-07 | 190 | 338 | 11 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff |
| ToppCell | severe-Lymphocytic-Plasmablast|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | HSP90B2P IGLL5 GMPPA CCR10 CAV1 IGHG1 IGHG2 IGHG3 IGHG4 IGLC2 IGLC3 | 2.54e-07 | 191 | 338 | 11 | 73660d762c9d451980c21adc426db6670bcaf37f |
| ToppCell | COVID-19_Moderate-Plasmablast|World / disease group, cell group and cell class | IGLL5 CCR10 CAV1 IGHG1 IGHG2 IGHG3 IGHG4 CPEB4 IGLC2 IGLC3 IGLC6 | 2.54e-07 | 191 | 338 | 11 | bb28703020c5296b65527094d2e5924348275e58 |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-B_lymphocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | RPLP0 RPS21 IGLL5 ABCB4 ADK CAMK2D IGHG1 IGHG2 IGHG3 IGLC2 IGLC3 | 2.82e-07 | 193 | 338 | 11 | ddc06227f2580774d9f34729dff912d6a9155f9c |
| ToppCell | severe_COVID-19-B_intermediate|World / disease group, cell group and cell class (v2) | SIDT1 PEBP4 SNX9 ADAMTS6 IGHG1 IGHG2 IGHG3 IGHG4 IGLC2 IGLC3 PLCE1 | 2.97e-07 | 194 | 338 | 11 | cb346cb186fe80a8f490ae90b2539b3543ba0ca9 |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | THSD4 TBC1D4 MAST4 AKAP6 FRAS1 ANK2 SGCG CAMK2D FRY CPEB4 CDH2 | 2.97e-07 | 194 | 338 | 11 | c3535f7cc0076653c72db582047cff053c322397 |
| ToppCell | Bronchial_Biopsy-Immune-B_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | RPLP0 IGLL5 CCR10 CAV1 IGHG1 IGHG2 IGHG3 IGHG4 IGLC2 IGLC3 IGLC6 | 2.97e-07 | 194 | 338 | 11 | da0bdb9afeb9c4290cb10171836a045d3258ca97 |
| ToppCell | ILEUM-inflamed|ILEUM / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | TBC1D4 SMCHD1 LDHA IGHG1 IGHG2 IGHG3 IGHG4 HAPLN3 IGLC2 IGLC3 CTLA4 | 3.12e-07 | 195 | 338 | 11 | 661962a8bcd2b69894e889cb0681a5b0cdb8e819 |
| ToppCell | MS-plasma|MS / Condition, Cell_class and T cell subcluster | IGLL5 GMPPA CCR10 CAV1 IGHG1 IGHG2 IGHG3 IGHG4 IGLC2 IGLC3 IGLC6 | 3.12e-07 | 195 | 338 | 11 | de866c0eaec36d94a3101eb9f949ca9544207f33 |
| ToppCell | MS-plasma-|MS / Condition, Cell_class and T cell subcluster | IGLL5 GMPPA CCR10 CAV1 IGHG1 IGHG2 IGHG3 IGHG4 IGLC2 IGLC3 IGLC6 | 3.12e-07 | 195 | 338 | 11 | b0a51dea06899e6a4477c3436c85e114cd8f6214 |
| ToppCell | COVID-19_Severe|World / Disease condition and Cell class | CYLD RNMT DPP4 LDHA PPP1R14B IGHG1 IGHG2 IGHG3 IGHG4 IGLC2 IGLC3 | 3.29e-07 | 196 | 338 | 11 | 450ac2aff89c5ca73b8bfbc80663e03be066931f |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGLL5 CAV1 SLC25A22 POLR3B IGHG1 IGHG2 IGHG3 IGHG4 IGLC2 IGLC3 | 3.33e-07 | 156 | 338 | 10 | 5d9e1df70f2e9219f6b029be2e39297605d36726 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.54e-07 | 157 | 338 | 10 | 63502d0fd5972d71cdbe13bde167592c70acec32 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CDH26 DHRS3 MAST4 FGFR2 DNAH5 FHIP1A FLNB FRAS1 ADAMTSL1 P2RY6 OR6C2 | 3.64e-07 | 198 | 338 | 11 | 1408e02e053ad3406229bfe8189da03be6366e81 |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CDH26 DHRS3 MAST4 FGFR2 DNAH5 FHIP1A FLNB FRAS1 ADAMTSL1 P2RY6 OR6C2 | 3.64e-07 | 198 | 338 | 11 | af399569c718f5fd971d73a7926768c9311002a3 |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | IGLL5 CAV1 POLR3B IGHG1 IGHG2 IGHG3 IGHG4 IGLC2 IGLC3 PCDHGC3 | 3.75e-07 | 158 | 338 | 10 | 1397078f909338fa5fa3b01748db891e5e3fc9e7 |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | IGLL5 CAV1 POLR3B IGHG1 IGHG2 IGHG3 IGHG4 IGLC2 IGLC3 PCDHGC3 | 3.75e-07 | 158 | 338 | 10 | e5451cfe67e882eb0c1eca287740f8ab75370abc |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | IGLL5 CAV1 POLR3B IGHG1 IGHG2 IGHG3 IGHG4 IGLC2 IGLC3 PCDHGC3 | 3.75e-07 | 158 | 338 | 10 | 17a13c5719eb363f2eb8f1d4e171429c6a1ce1e9 |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-B-Plasmablast|COVID-19_Severe / Disease, condition lineage and cell class | EPRS1 IGLL5 GMPPA CCR10 CAV1 IGHG1 IGHG2 IGHG3 IGHG4 IGLC2 IGLC3 | 3.82e-07 | 199 | 338 | 11 | e6422b65e22e5aa8dfaebdae5be76dd78b978604 |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGLL5 CAV1 POLR3B IGHG1 IGHG2 IGHG3 IGHG4 IGLC2 IGLC3 PCDHGC3 | 3.98e-07 | 159 | 338 | 10 | 6ecc3cb2daa5887b59836842be414a00cdcdaeec |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGLL5 CAV1 POLR3B IGHG1 IGHG2 IGHG3 IGHG4 IGLC2 IGLC3 PCDHGC3 | 3.98e-07 | 159 | 338 | 10 | 1827493fb464bbddb2ee23f99472cfbcaf57405b |
| ToppCell | Sepsis-Int-URO-Lymphocyte-B-B_intermediate|Int-URO / Disease, condition lineage and cell class | IGLL5 PEBP4 ABCB4 ADK ADAMTS6 IGHG1 IGHG2 IGHG3 IGHG4 IGLC2 IGLC3 | 4.02e-07 | 200 | 338 | 11 | 221dd8d8851c47f2202ba848de3a041b17b1db3f |
| ToppCell | 368C-Lymphocytic-Plasma_cell-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.73e-07 | 162 | 338 | 10 | c21a54310b239d999bbc9d8fb5e8fda16e0bc336 | |
| ToppCell | 368C-Lymphocytic-Plasma_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.73e-07 | 162 | 338 | 10 | f945688815229c8386cbcbf46deee7df316fa8d3 | |
| ToppCell | Mild_COVID-19-B_cell-Plasmablast|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | IGLL5 CAV1 POLR3B IGHG1 IGHG2 IGHG3 IGHG4 IGLC2 IGLC3 PCDHGC3 | 4.73e-07 | 162 | 338 | 10 | b67f6fb3d7f6093c8ef02398ff8fea4d0fb41a3b |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B_plasma-Plasmablasts|bone_marrow / Manually curated celltypes from each tissue | 5.29e-07 | 164 | 338 | 10 | 67260e9f569f0acaeb0e65f69cde230f91cd3d26 | |
| ToppCell | Basal_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 6.60e-07 | 168 | 338 | 10 | 48089fa2d4a0f31a72405717119b767a92571f01 | |
| ToppCell | tumor_Lung-B_lymphocytes-Plasma_cells|tumor_Lung / Location, Cell class and cell subclass | 6.97e-07 | 169 | 338 | 10 | b36b7632ce55fc7b6b8b66020563d360b3de6fd7 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | JAK2 TBC1D4 NECTIN1 FGFR1 TNS3 DPP4 DPY19L1 P2RY6 DKK3 PLCE1 | 8.19e-07 | 172 | 338 | 10 | 979fd7b435f59b8a4d290a809cf76147d4c63d48 |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | JAK2 TBC1D4 NECTIN1 FGFR1 TNS3 DPP4 DPY19L1 P2RY6 DKK3 PLCE1 | 8.19e-07 | 172 | 338 | 10 | f4d7f416802218ce56408fa4cb8a555d846bc85b |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B_plasma-Plasma_cells|bone_marrow / Manually curated celltypes from each tissue | 8.63e-07 | 173 | 338 | 10 | 300904fd35536a69be81d76fe33fe16544523ceb | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | UNC13D FHIP1B TBC1D4 POLN TMPRSS7 CPEB2 FAT3 SLC18A2 SYTL1 CXCR2 | 8.63e-07 | 173 | 338 | 10 | 117163c5cd2b7aaa1c0682c8ac44b4249df4d2f8 |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | UNC13D FHIP1B TBC1D4 POLN TMPRSS7 CPEB2 FAT3 SLC18A2 SYTL1 CXCR2 | 8.63e-07 | 173 | 338 | 10 | 01df9baeedf30e3a4891738554cdd300394dbb96 |
| ToppCell | Influenza_Severe-B_intermediate|Influenza_Severe / Disease group and Cell class | 9.10e-07 | 174 | 338 | 10 | 4276bdaac53aebd3084323a90ecde572d3177446 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 9.10e-07 | 174 | 338 | 10 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B_plasma|bone_marrow / Manually curated celltypes from each tissue | 9.10e-07 | 174 | 338 | 10 | b1931028cf80af5eff6da15d7f0196205f17926f | |
| ToppCell | (5)_Plasma-(5)_Plasma_IgG|(5)_Plasma / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.01e-06 | 70 | 338 | 7 | bfe020c111a27337ed4dc6ee59b74bc36b03eb49 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SDSL PANK1 FAAH TBC1D4 POLN TMPRSS7 FLNB ADAMTSL1 SLC45A3 SLC18A2 | 1.06e-06 | 177 | 338 | 10 | 9b4c1ca5c6fca9a7a936dad49a04155903ef9c32 |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAAH ADK JAK2 TBC1D4 POLN FLNB ADAMTSL1 FAT3 SLC45A3 SLC18A2 | 1.06e-06 | 177 | 338 | 10 | c1f838e425ebb04482829b1957e3c1347127e6de |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-06 | 178 | 338 | 10 | 41745a589567ca5ea6d06331f4c8da03595b5f5c | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-06 | 178 | 338 | 10 | eb940dd64c973f68bcaad6069d3bd56383329db5 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.18e-06 | 179 | 338 | 10 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 1.24e-06 | 180 | 338 | 10 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | GPR37L1 SLC29A2 GGT7 TESK2 PLXNB3 AKAP6 TRIM46 FLNC CSMD1 CDH2 | 1.24e-06 | 180 | 338 | 10 | 1e819c5c87704ec6535dfeaae56561895e239d07 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-06 | 180 | 338 | 10 | 65c069585737302a69b9a01476f4eb8b50cb2bfd | |
| ToppCell | 356C-Lymphocytic-Plasma_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-06 | 181 | 338 | 10 | f1d88b83a13acd1c8e6b9ff8bd0acaff3650ceef | |
| ToppCell | 356C-Lymphocytic-Plasma_cell-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-06 | 181 | 338 | 10 | 70cd612706640d8ebf0e047582b1daa2c1121526 | |
| ToppCell | COPD-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 1.37e-06 | 182 | 338 | 10 | 19db653fe04c5e2957eea1f4893b1c1fca4ddcbd | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Plasma_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.43e-06 | 142 | 338 | 9 | 5ba3a33c2ee20be8baaed97536ca6e9d1de6752f | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B_plasma-Plasma_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 1.44e-06 | 183 | 338 | 10 | a6866951866373a1029e04818f4a4a31278c409d | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B_plasma|lymph-node_spleen / Manually curated celltypes from each tissue | 1.44e-06 | 183 | 338 | 10 | beadc69f511cf183e493cb445135f0748ab8b20e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-06 | 184 | 338 | 10 | f81209e6bc01a0140f4487aa8b22eb02fbf0c39c | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-CD5+_CCL22+_mature_B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | IGLL5 CCR10 ADAMTS6 IGHG1 IGHG2 IGHG3 IGHG4 IGLC2 IGLC3 IGLC6 | 1.51e-06 | 184 | 338 | 10 | 5bb775253a10a14360b06a46aba46d162a9bd1f8 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.59e-06 | 185 | 338 | 10 | 96423bdcf0e85ca41370f79347d27c22f3de98f5 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.59e-06 | 185 | 338 | 10 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | Control-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 1.59e-06 | 185 | 338 | 10 | d5d6d13e2f20b54ca55645b9a757b8599f4fd897 | |
| ToppCell | mild-Lymphocytic-Plasmablast|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | HSP90B2P IGLL5 CCR10 CAV1 IGHG1 IGHG2 IGHG3 IGHG4 IGLC2 IGLC3 | 1.67e-06 | 186 | 338 | 10 | 060510c21b1e0889b7a6eeb15821b9e2f03a0f99 |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Plasma_cells|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-06 | 186 | 338 | 10 | b9fb7210f615faff0633a1c82dd3be38cb72a00b | |
| ToppCell | Children_(3_yrs)-Immune-B_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.67e-06 | 186 | 338 | 10 | aa576748921a318798b911a611f05319b95e8d5e | |
| ToppCell | IPF-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 1.67e-06 | 186 | 338 | 10 | f9c21daf905d0bb0e0e769ca4bb069ea4b1ba25b | |
| ToppCell | severe_influenza-B_intermediate|severe_influenza / disease group, cell group and cell class (v2) | 1.75e-06 | 187 | 338 | 10 | d6db8595aa72fdabc4a056ba6ce09876868a66d5 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Plasma_cells|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-06 | 187 | 338 | 10 | 31f36e34669b8fff6905262b4661b59c93e4dc3d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.75e-06 | 187 | 338 | 10 | d2296f2722a24b289fed7e6cfdc2105608437c3e | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.75e-06 | 187 | 338 | 10 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.75e-06 | 187 | 338 | 10 | 06a0f0a27569af89f86ed8cddb608454a3d40cc5 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.84e-06 | 188 | 338 | 10 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | (10)_B_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 1.84e-06 | 188 | 338 | 10 | fa1346902021c3a6557555ada0fd37b29cf9d5ec | |
| ToppCell | (1)_B_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 1.84e-06 | 188 | 338 | 10 | 642a334f2d5b6dc9df4a9fa0558833bd37bd3c58 | |
| ToppCell | 10x5'-blood-Lymphocytic_B_plasma-Plasma_cells|blood / Manually curated celltypes from each tissue | 1.90e-06 | 147 | 338 | 9 | 58089378fac1743ce99dc4f1bd7b5253a927f050 | |
| ToppCell | BAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.92e-06 | 189 | 338 | 10 | b0fcbe13a91a4b8dfa507b7a484f45477ef31609 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.92e-06 | 189 | 338 | 10 | 73ee4cfb1057832f700be59b6917dedde3e89880 | |
| ToppCell | 356C-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.92e-06 | 189 | 338 | 10 | 0994aba7a44577a8943af237c9c3575502d0584c | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.92e-06 | 189 | 338 | 10 | c296660061b46e3abae1e7cf29df20274e5a8add | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.92e-06 | 189 | 338 | 10 | f2daf4889ef98bbefe3e44832618ac102a75b4d9 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.85e-07 | 49 | 204 | 9 | GAVISH_3CA_MALIGNANT_METAPROGRAM_36_IG | |
| Drug | alpha-conotoxin MII | 4.55e-08 | 4 | 334 | 4 | ctd:C098872 | |
| Drug | sodium | ABCC3 RPLP0 ACTRT3 SLC29A2 CHRNA3 CHRNA4 RYR1 CHRNB2 PHEX TRPM5 SLC5A6 SCN4B KCNJ16 OXSM MCAT PGP WNK3 ATP8B3 DPP4 CHRNA6 ANK2 ACTRT2 CHORDC1 LDHA SLCO1B1 SLC7A14 SLC6A11 KLK4 ATP2C1 SLC15A1 P2RY6 P2RX2 SLC18A2 XPNPEP3 SLC24A1 SLC2A11 | 1.80e-07 | 944 | 334 | 36 | CID000000923 |
| Drug | decamethonium | 6.67e-07 | 6 | 334 | 4 | ctd:C033019 | |
| Drug | Clozapine [5786-21-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A | GPR37L1 ZZEF1 STAC ABCB4 SPON1 FGFR2 NOVA2 AKAP6 CPEB3 SLCO1B1 RGS12 PPP2CB SLC15A1 SLC24A1 | 1.38e-06 | 197 | 334 | 14 | 5630_UP |
| Drug | Dimethylphenylpiperazinium Iodide | 3.04e-06 | 8 | 334 | 4 | ctd:D004246 | |
| Drug | epibatidine | 3.04e-06 | 8 | 334 | 4 | ctd:C082748 | |
| Drug | AC1LCVGE | 4.83e-06 | 18 | 334 | 5 | CID000656712 | |
| Drug | pozanicline | 5.41e-06 | 9 | 334 | 4 | ctd:C108326 | |
| Drug | 1,2-dithiol-3-thione | CAND1 RNMT RPLP0 ETFA PFKFB1 CHRNA3 ABCB4 JAK2 FASN PSME4 PER2 PIK3C3 DPP4 FLNC DOCK8 CAMK2D CHORDC1 APP PPAT GSR CASK DNAH1 PPP2CA ATP2C1 IGF2R TIMP2 CTLA4 IL6R ACSL5 CDK5 | 5.70e-06 | 829 | 334 | 30 | ctd:C049325 |
| Drug | AC1MRGT8 | 6.06e-06 | 67 | 334 | 8 | CID003517815 | |
| Drug | Felodipine [72509-76-3]; Down 200; 10.4uM; MCF7; HT_HG-U133A | SUPT6H TESK2 PGAP1 GMPPA CACNB3 CAMK2G RALGAPB CAV1 APP MMACHC ATP2C1 TIMP2 MAPKBP1 | 7.02e-06 | 196 | 334 | 13 | 5294_DN |
| Drug | pioglitazone | SPAG8 SLC29A2 RYR1 CFHR4 FANCB FASN TBC1D4 PER2 PIK3C3 PGP DPP4 APP SLCO1B1 TIMP2 FSHB SLC2A11 ACSL5 | 7.34e-06 | 326 | 334 | 17 | CID000004829 |
| Drug | phenanthroline | 7.98e-06 | 50 | 334 | 7 | CID000067473 | |
| Drug | AC1NQGK1 | 1.04e-05 | 52 | 334 | 7 | CID005195977 | |
| Drug | beta-erythroidine | 1.24e-05 | 4 | 334 | 3 | ctd:C004873 | |
| Drug | 2-(1'-methyl-2'-pyrrolidinyl)-7-hydroxy-1,4-benzodioxane | 1.24e-05 | 4 | 334 | 3 | ctd:C569671 | |
| Drug | 2-vanillin | 1.24e-05 | 4 | 334 | 3 | ctd:C060843 | |
| Drug | Anabasine | 1.24e-05 | 4 | 334 | 3 | ctd:D000691 | |
| Drug | diphenylacetic acid | 1.24e-05 | 4 | 334 | 3 | ctd:C037760 | |
| Drug | hydratropic acid | 1.24e-05 | 4 | 334 | 3 | ctd:C013025 | |
| Drug | S)-cotinine | CYLD CHRNA3 CHRNA4 CHRNB2 UGT2B10 CHRNA6 UGT1A10 UGT1A8 UGT1A7 | 1.30e-05 | 97 | 334 | 9 | CID000000408 |
| Drug | cytisine | 1.38e-05 | 11 | 334 | 4 | ctd:C004712 | |
| Drug | N-methyl-DL-aspartic acid | EPHB3 SDSL GAD2 CHRNA3 CHRNA4 RYR1 CHRNB2 PER2 PIK3C3 SCN4B KCNJ16 CHRNA6 CACNB3 DRD2 CAMK2D CAMK2G APP LDHA GSR CASK CPEB4 SLC24A1 CDH2 CXCR2 CDK5 | 1.45e-05 | 655 | 334 | 25 | CID000004376 |
| Drug | Lanatoside C [17575-22-3]; Down 200; 4uM; MCF7; HT_HG-U133A | WDR4 TMCO6 WDR3 JAK2 TGFBRAP1 OXSM PAAF1 CCNF POLR3B HPS6 SLC24A1 PUS7L | 1.77e-05 | 183 | 334 | 12 | 3963_DN |
| Drug | hemicholinium-3 | 1.89e-05 | 78 | 334 | 8 | CID000003585 | |
| Drug | Mebendazole [31431-39-7]; Down 200; 13.6uM; HL60; HT_HG-U133A | FTSJ1 SLC29A2 CHRNA5 WDR3 TGFBRAP1 PLCB4 DDX49 APP MMACHC CASK P2RY6 IL6R | 1.97e-05 | 185 | 334 | 12 | 2338_DN |
| Drug | dG-8-AF | 2.05e-05 | 12 | 334 | 4 | CID000104947 | |
| Drug | AC1L1BQX | 2.08e-05 | 79 | 334 | 8 | CID000001565 | |
| Drug | anabaseine | 2.23e-05 | 24 | 334 | 5 | CID000018985 | |
| Drug | intruder | 2.23e-05 | 24 | 334 | 5 | CID000213021 | |
| Drug | bupropion | 2.50e-05 | 81 | 334 | 8 | CID000000444 | |
| Drug | procainamide | NAT2 ERCC1 CHRNA3 CHRNA4 CHRNB2 HPS4 NECTIN1 SCN4B HSPG2 CHRNA6 CR1L FSHB | 2.57e-05 | 190 | 334 | 12 | CID000004913 |
| Drug | bipinnatin-C | 2.93e-05 | 13 | 334 | 4 | CID000129977 | |
| Drug | cotinine-N-glucuronide | 2.93e-05 | 13 | 334 | 4 | CID000000411 | |
| Drug | bipinnatin-A | 2.93e-05 | 13 | 334 | 4 | CID000196603 | |
| Drug | 2-hydroxyestrone | 2.93e-05 | 13 | 334 | 4 | ctd:C024980 | |
| Drug | isovaleric acid | 3.06e-05 | 5 | 334 | 3 | ctd:C008216 | |
| Drug | naringenin chalcone | 3.06e-05 | 5 | 334 | 3 | ctd:C027329 | |
| Drug | N-(1,2,3,4-tetrahydro-1-naphthyl)-4-nitroaniline | 3.06e-05 | 5 | 334 | 3 | ctd:C524978 | |
| Drug | cisatracurium | 3.06e-05 | 5 | 334 | 3 | ctd:C101584 | |
| Drug | anthrarobin | 3.06e-05 | 5 | 334 | 3 | ctd:C032186 | |
| Drug | biphenylylacetic acid | 3.06e-05 | 5 | 334 | 3 | ctd:C012776 | |
| Drug | Bromperidol [10457-90-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A | EPHB3 RNMT IRF2BP1 SIK1 JAK2 SUPT6H PGAP1 FGFR2 ADGRL1 ANKEF1 XPNPEP3 MAPKBP1 | 3.16e-05 | 194 | 334 | 12 | 7457_DN |
| Drug | PTBP | 3.20e-05 | 42 | 334 | 6 | CID000007393 | |
| Drug | Thymol | 3.37e-05 | 26 | 334 | 5 | ctd:D013943 | |
| Drug | Diflorasone Diacetate [33564-31-7]; Down 200; 8uM; MCF7; HT_HG-U133A | CYLD NR2F6 WWOX DHRS3 ZZEF1 FAAH CHST12 FGFR1 HSPG2 DMXL2 GPR37 PCSK6 | 3.49e-05 | 196 | 334 | 12 | 2798_DN |
| Drug | 2-acetylaminofluorene | NAT2 ABCC3 NR2F6 ERCC1 IGSF6 POLA2 ABCB4 GGT7 PROM1 UGT2B10 POLN RAD23A XPC TG | 3.60e-05 | 262 | 334 | 14 | CID000005897 |
| Drug | Mebendazole [31431-39-7]; Down 200; 13.6uM; MCF7; HT_HG-U133A | EPHB3 WWOX WDR4 USP20 PHKB TDRD3 SUPT6H TESK2 HPS4 CHST12 RBM4B SETD2 | 3.67e-05 | 197 | 334 | 12 | 2300_DN |
| Drug | Demecarium bromide [56-94-0]; Down 200; 5.6uM; MCF7; HT_HG-U133A | TMCO6 MAST4 PGAP1 TNS3 FLNB CACNB3 RALGAPB FBXO11 APP TFAP2C XPNPEP3 KDM1A | 3.86e-05 | 198 | 334 | 12 | 6269_DN |
| Drug | glycerol | EPRS1 GAD2 ERCC1 WWOX WDR4 NAIP SIGLEC5 PFKFB1 POLA2 CLIP1 FASN SUPT6H OXSM MCAT PGP POLN APP PPAT LDHA GSR DERA POLR3B IGF2R XPNPEP3 SMARCA1 LGALS13 M6PR KDM1A | 4.05e-05 | 829 | 334 | 28 | CID000000753 |
| Drug | Varenicline | 4.05e-05 | 14 | 334 | 4 | ctd:D000068580 | |
| Drug | Scopoletin | 4.08e-05 | 27 | 334 | 5 | ctd:D012603 | |
| Drug | ethylnylestradiol | ABCC3 NR2F6 IGSF6 ACTRT3 CLIP1 F12 CFHR4 GGT7 JAK2 PROM1 HPS4 C1QTNF5 CCR10 DRD2 UGT1A10 UGT1A8 UGT1A7 CH25H MACROD1 ACTRT2 XPC CAV1 LDHA TFAP2C GSR CHST8 TG SLC6A11 ATP2C1 IGF2R FSHB SMARCA1 CTLA4 M6PR SLC2A11 KDM1A CXCR2 | 4.17e-05 | 1251 | 334 | 37 | CID000003285 |
| Drug | Etidronic acid, disodium salt [7414-83-7]; Up 200; 16uM; MCF7; HT_HG-U133A | STAC ABCB4 FGFR2 CHRNA6 FRAS1 CR1 SUGCT FSHB SMARCA1 PHF14 CXCR2 PLCE1 | 4.25e-05 | 200 | 334 | 12 | 4387_UP |
| Drug | ciprofibrate | ABCC3 RYR1 ABCB4 CFHR4 GGT7 FANCB UGT1A10 UGT1A8 UGT1A7 CHD9 HADHA | 4.46e-05 | 170 | 334 | 11 | CID000002763 |
| Drug | manganese | NAT2 WWOX ACTRT3 POLA2 CHRNA3 CHRNA4 RYR1 CHRNB2 PHKB NECTIN1 OXSM MCAT POLN CHRNA6 CACNB3 ACTRT2 CAV1 APP PPAT LDHA PPP2CA POLR3B ATP2C1 P2RX2 XPNPEP3 CTLA4 M6PR | 4.66e-05 | 791 | 334 | 27 | CID000023930 |
| Drug | N-hydroxy-4-aminobiphenyl | 4.91e-05 | 28 | 334 | 5 | CID000081261 | |
| Drug | CHEMBL35507 | 4.91e-05 | 28 | 334 | 5 | CID013671153 | |
| Drug | CPD-4 | 5.38e-05 | 90 | 334 | 8 | CID000000459 | |
| Drug | coumarin-3-carboxylic acid | 5.46e-05 | 15 | 334 | 4 | CID000010752 | |
| Drug | (-)-pictamine | 5.46e-05 | 15 | 334 | 4 | CID006918623 | |
| Drug | (-)-lepadin B | 5.46e-05 | 15 | 334 | 4 | CID006918624 | |
| Drug | UB-165 | 5.46e-05 | 15 | 334 | 4 | CID004694339 | |
| Drug | AC1Q5HK6 | ABCC3 GAD2 SPAG8 CLIP1 CHRNA3 CHRNA4 CHRNB2 GGT7 C1QTNF5 NCR1 SNX9 CHRNA6 CH25H CR1L TG KLK4 IGF2R FSHB M6PR IL6R | 5.71e-05 | 501 | 334 | 20 | CID000003640 |
| Drug | 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine | 5.86e-05 | 29 | 334 | 5 | ctd:C060533 | |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 6.06e-05 | 6 | 334 | 3 | ctd:C543211 | |
| Drug | alloin | 6.06e-05 | 6 | 334 | 3 | ctd:C006457 | |
| Drug | 3-phenylpropionic acid | 6.06e-05 | 6 | 334 | 3 | ctd:C035253 | |
| Drug | Indoprofen | 6.06e-05 | 6 | 334 | 3 | ctd:D007216 | |
| Drug | Palifermin | 6.06e-05 | 6 | 334 | 3 | DB00039 | |
| Drug | Pyridines | 6.06e-05 | 6 | 334 | 3 | ctd:D011725 | |
| Drug | 2',5'-dihydroxychalcone | 6.06e-05 | 6 | 334 | 3 | ctd:C107497 | |
| Drug | AC1L9E0Q | 6.95e-05 | 30 | 334 | 5 | CID000443095 | |
| Drug | retigabine | 6.96e-05 | 48 | 334 | 6 | CID000121892 | |
| Drug | pentachlorophenol | 7.09e-05 | 120 | 334 | 9 | CID000000992 | |
| Drug | Hexamethonium | 7.20e-05 | 16 | 334 | 4 | ctd:D018738 | |
| Drug | AC1L2SVN | 7.20e-05 | 16 | 334 | 4 | CID000127922 | |
| Drug | Lanatoside C [17575-22-3]; Down 200; 4uM; MCF7; HT_HG-U133A | TMCO6 WDR3 JAK2 TDRD3 OXSM CCNF POLR3B ANKEF1 HPS6 SLC24A1 PUS7L | 7.88e-05 | 181 | 334 | 11 | 6048_DN |
| Drug | CoA group | NAT2 SDSL WWOX ACTRT3 ACADVL PANK1 FASN OXSM MCAT ACTRT2 PPAT LDHA SLCO1B1 GSR DERA SUGCT HADHA ACSL5 | 8.04e-05 | 433 | 334 | 18 | CID000000317 |
| Drug | AC1L1JK6 | 8.19e-05 | 31 | 334 | 5 | CID000005077 | |
| Drug | NSC7524 | GAD2 CHRNA3 CHRNA4 RYR1 CHRNB2 SCN4B CHRNA6 CACNB3 DRD2 LDHA SLC6A11 | 8.28e-05 | 182 | 334 | 11 | CID000005657 |
| Drug | Ibuprofen | EPRS1 SIK1 IP6K1 PANK1 FAAH FASN ADPRS MCAT NOVA2 UGT1A10 UGT1A8 UGT1A7 APP TIPARP IGF2R SLC15A1 IGHG3 IGLC1 | 9.03e-05 | 437 | 334 | 18 | ctd:D007052 |
| Drug | glutamate | EPRS1 GAD2 WWOX ACTRT3 CHRNA3 CHRNA4 RYR1 CHRNB2 NIT2 GGT7 TRPM5 PER2 SCN4B KCNJ16 PLCB4 CHRNA6 CACNB3 DRD2 CAMK2D ACTRT2 PPAT LDHA LECT2 GSR SLC25A22 SLC6A11 P2RX2 HADHA CDK5 PLCE1 | 9.13e-05 | 962 | 334 | 30 | CID000000611 |
| Drug | CoA disulfide | 9.31e-05 | 17 | 334 | 4 | CID000169341 | |
| Drug | L-2-amino-6-oxopimelate | 9.31e-05 | 17 | 334 | 4 | CID000194695 | |
| Drug | 2,3,7,8-tetrachlorodibenzofuran | ABCC3 DHRS3 PFKFB1 SLC29A2 PGAP6 ABCB4 GPR146 PROM1 MFGE8 FASN SCN4B DPP4 GSR TIPARP TYW1 TMEM19 IL6R | 9.40e-05 | 399 | 334 | 17 | ctd:C014211 |
| Drug | nitrite ion | GAD2 WWOX NIT2 NIT1 OXSM FGFR1 PLCB4 MCAT FGFR2 DNAH5 SGCG GSR NMI | 1.01e-04 | 253 | 334 | 13 | CID000000946 |
| Drug | NSC406942 | ERCC1 WWOX ACTRT3 POLA2 RYR1 PGAP1 OXSM PGP POLN DNAH9 NOVA2 RAD23A ACTRT2 CAV1 PPAT CR1L TG ATP2C1 HPS6 M6PR ACSL5 | 1.03e-04 | 565 | 334 | 21 | CID000001115 |
| Drug | mivacurium | 1.05e-04 | 7 | 334 | 3 | ctd:C049430 | |
| Drug | 2',4'-dihydroxychalcone | 1.05e-04 | 7 | 334 | 3 | ctd:C059354 | |
| Drug | Atracurium | 1.05e-04 | 7 | 334 | 3 | ctd:D001279 | |
| Drug | EPTC | 1.05e-04 | 7 | 334 | 3 | ctd:C036251 | |
| Drug | BP-3,6-quinol | 1.12e-04 | 33 | 334 | 5 | CID000119292 | |
| Drug | methyllycaconitine | 1.12e-04 | 33 | 334 | 5 | ctd:C054634 | |
| Drug | 6-methylsalicylic acid | 1.12e-04 | 33 | 334 | 5 | CID000011279 | |
| Drug | Cocaine | EPHB3 ABCC3 GAD2 CPNE8 USP9X ETFA CLIP1 SLC29A2 CHRNA3 CHRNA4 CHRNA5 CHRNB2 NIT2 PSME4 PER2 FGFR1 HERC1 RECK WNK3 PLEKHA8 SEMA6C CACNB3 FRAS1 SATB2 DRD2 UGT1A8 ADGRL1 APP GSR DHX30 PPP2CA PPP2CB TENM4 SLC18A2 PCDHGC3 ACSL5 CDK5 | 1.14e-04 | 1314 | 334 | 37 | ctd:D003042 |
| Drug | gemfibrozil | NAIP ABCB4 CFHR4 HPS4 UGT1A10 UGT1A8 UGT1A7 SLCO1B1 TG NOP58 ACSL5 DCP1A | 1.16e-04 | 222 | 334 | 12 | CID000003463 |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; PC3; HT_HG-U133A | ABCC3 IRF2BP1 TMCO6 POLA2 USP20 RECK APP TENM4 PAK3 SLC24A1 PUS7L | 1.16e-04 | 189 | 334 | 11 | 3733_DN |
| Drug | catechol | WWOX SIDT1 HDAC3 UGT2B10 DNAH5 DRD2 GPR37 UGT1A10 UGT1A8 UGT1A7 GSR NOP58 SLC18A2 | 1.18e-04 | 257 | 334 | 13 | CID000000289 |
| Drug | Mpt-gmp | 1.18e-04 | 18 | 334 | 4 | CID000000498 | |
| Disease | X-21339 measurement | 5.24e-07 | 7 | 330 | 4 | EFO_0800808 | |
| Disease | serum N-desmethylclozapine measurement | 1.04e-06 | 8 | 330 | 4 | EFO_0600043 | |
| Disease | X-11880 measurement | 1.85e-06 | 9 | 330 | 4 | EFO_0800698 | |
| Disease | otitis media (implicated_via_orthology) | 3.82e-06 | 22 | 330 | 5 | DOID:10754 (implicated_via_orthology) | |
| Disease | X-21796 measurement | 4.77e-06 | 11 | 330 | 4 | EFO_0800825 | |
| Disease | plasma N-desmethylclozapine measurement | 4.77e-06 | 11 | 330 | 4 | EFO_0600039 | |
| Disease | TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) | 7.08e-06 | 12 | 330 | 4 | C1861063 | |
| Disease | biliverdin measurement | 7.08e-06 | 12 | 330 | 4 | EFO_0021033 | |
| Disease | 5-hydroxyindole sulfate measurement | 1.36e-05 | 5 | 330 | 3 | EFO_0800085 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 1.36e-05 | 5 | 330 | 3 | EFO_0801060 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 1.36e-05 | 5 | 330 | 3 | EFO_0801853 | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 2.51e-05 | 16 | 330 | 4 | DOID:3635 (implicated_via_orthology) | |
| Disease | nicotine dependence (is_implicated_in) | 2.70e-05 | 6 | 330 | 3 | DOID:0050742 (is_implicated_in) | |
| Disease | Mental Depression | CHRNA4 PER2 FGFR1 FGFR2 DPP4 CHRNA6 DRD2 APP LDHA SLC18A2 M6PR IL6R | 3.26e-05 | 254 | 330 | 12 | C0011570 |
| Disease | X-21441 measurement | 3.26e-05 | 17 | 330 | 4 | EFO_0800814 | |
| Disease | Seizures | GAD2 PLPPR1 CHRNA3 CHRNA4 CHRNA5 FAAH ADPRS SLC5A6 DRD2 APP PPP2CA | 3.81e-05 | 218 | 330 | 11 | C0036572 |
| Disease | Drug Withdrawal Symptoms | 4.64e-05 | 58 | 330 | 6 | C0086189 | |
| Disease | Withdrawal Symptoms | 4.64e-05 | 58 | 330 | 6 | C0087169 | |
| Disease | Substance Withdrawal Syndrome | 4.64e-05 | 58 | 330 | 6 | C0038587 | |
| Disease | Autosomal Dominant Nocturnal Frontal Lobe Epilepsy | 4.69e-05 | 7 | 330 | 3 | C3696898 | |
| Disease | Schizophrenia | GAD2 CHRNA3 CHRNA4 CHRNA5 CHRNB2 ADK HDAC3 PIK3C3 HPS4 FGFR1 MCAT FGFR2 WNK3 DRD2 CAV1 RGS12 SLC6A11 TENM4 SLC18A2 CTLA4 CSMD1 IL6R DKK3 CDK5 | 6.56e-05 | 883 | 330 | 24 | C0036341 |
| Disease | Succinimide measurement | 7.45e-05 | 8 | 330 | 3 | EFO_0022118 | |
| Disease | cholelithiasis, bilirubin measurement | 7.45e-05 | 8 | 330 | 3 | EFO_0004570, EFO_0004799 | |
| Disease | X-24849 measurement | 7.45e-05 | 8 | 330 | 3 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 7.45e-05 | 8 | 330 | 3 | EFO_0802740 | |
| Disease | X-16946 measurement | 7.45e-05 | 8 | 330 | 3 | EFO_0800766 | |
| Disease | X-11793--oxidized bilirubin measurement | 7.45e-05 | 8 | 330 | 3 | EFO_0021260 | |
| Disease | X-11530 measurement | 7.45e-05 | 8 | 330 | 3 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 7.45e-05 | 8 | 330 | 3 | EFO_0801034 | |
| Disease | X-11522 measurement | 7.45e-05 | 8 | 330 | 3 | EFO_0800696 | |
| Disease | X-10458 measurement | 7.45e-05 | 8 | 330 | 3 | EFO_0800692 | |
| Disease | plasma clozapine measurement | 7.45e-05 | 8 | 330 | 3 | EFO_0600038 | |
| Disease | Malignant neoplasm of breast | NAT2 TRIML1 NR2F6 WWOX CD109 HEPACAM2 CLIP1 FAAH PHKB MFGE8 FASN PER2 OXSM FGFR1 FGFR2 DNAH9 PLEKHA8 AKAP6 FLNB ANK2 CAV1 SLCO1B1 SETD2 NISCH ANKEF1 CDH2 VPS13B | 8.57e-05 | 1074 | 330 | 27 | C0006142 |
| Disease | X-11442 measurement | 1.11e-04 | 9 | 330 | 3 | EFO_0021236 | |
| Disease | X-11441 measurement | 1.11e-04 | 9 | 330 | 3 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 1.11e-04 | 9 | 330 | 3 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 1.11e-04 | 9 | 330 | 3 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 1.11e-04 | 9 | 330 | 3 | EFO_0801036 | |
| Disease | protein-tyrosine kinase 6 measurement | 1.11e-04 | 9 | 330 | 3 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 1.11e-04 | 9 | 330 | 3 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 1.11e-04 | 9 | 330 | 3 | EFO_0004570, GO_0009410 | |
| Disease | liver cancer (is_marker_for) | 1.11e-04 | 9 | 330 | 3 | DOID:3571 (is_marker_for) | |
| Disease | Depressive disorder | CHRNA4 PER2 FGFR1 FGFR2 DPP4 CHRNA6 DRD2 APP TG SLC18A2 M6PR IL6R | 1.12e-04 | 289 | 330 | 12 | C0011581 |
| Disease | Smoking as a quantitative trait locus 3 | 1.25e-04 | 2 | 330 | 2 | cv:C3150168 | |
| Disease | FGFR2-related craniosynostosis | 1.25e-04 | 2 | 330 | 2 | cv:CN231480 | |
| Disease | PFEIFFER SYNDROME | 1.25e-04 | 2 | 330 | 2 | 101600 | |
| Disease | Early myoclonic encephalopathy | 1.25e-04 | 2 | 330 | 2 | C0270855 | |
| Disease | Pfeiffer type acrocephalosyndactyly | 1.25e-04 | 2 | 330 | 2 | C2931888 | |
| Disease | Jackson-Weiss syndrome | 1.25e-04 | 2 | 330 | 2 | cv:C0795998 | |
| Disease | JACKSON-WEISS SYNDROME | 1.25e-04 | 2 | 330 | 2 | 123150 | |
| Disease | Pfeiffer syndrome (implicated_via_orthology) | 1.25e-04 | 2 | 330 | 2 | DOID:14705 (implicated_via_orthology) | |
| Disease | JACKSON-WEISS SYNDROME | 1.25e-04 | 2 | 330 | 2 | C0795998 | |
| Disease | Statin causing adverse effect in therapeutic use | 1.25e-04 | 2 | 330 | 2 | cv:C0570410 | |
| Disease | Cutis Gyrata Syndrome of Beare And Stevenson | 1.25e-04 | 2 | 330 | 2 | C1852406 | |
| Disease | Down syndrome (biomarker_via_orthology) | 1.25e-04 | 2 | 330 | 2 | DOID:14250 (biomarker_via_orthology) | |
| Disease | Statin-induced myopathy | 1.25e-04 | 2 | 330 | 2 | cv:CN181199 | |
| Disease | neural cell adhesion molecule 1 measurement | 1.25e-04 | 2 | 330 | 2 | EFO_0801826 | |
| Disease | – | 1.25e-04 | 2 | 330 | 2 | 612052 | |
| Disease | insulin growth factor-like family member 4 measurement | 1.25e-04 | 2 | 330 | 2 | EFO_0801701 | |
| Disease | Jackson-Weiss syndrome (is_implicated_in) | 1.25e-04 | 2 | 330 | 2 | DOID:0111337 (is_implicated_in) | |
| Disease | Pfeiffer syndrome | 1.25e-04 | 2 | 330 | 2 | cv:C0220658 | |
| Disease | Pfeiffer syndrome (is_implicated_in) | 1.25e-04 | 2 | 330 | 2 | DOID:14705 (is_implicated_in) | |
| Disease | immunoglobulin G measurement | 1.25e-04 | 2 | 330 | 2 | EFO_0020465 | |
| Disease | Hereditary Diffuse Gastric Cancer | ERCC1 WWOX RPS21 FGFR2 RAD23A CAV1 TFAP2C NAXD CDH2 M6PR IL6R PLCE1 | 1.27e-04 | 293 | 330 | 12 | C1708349 |
| Disease | Anxiety Disorders | 1.29e-04 | 44 | 330 | 5 | C0003469 | |
| Disease | Anxiety States, Neurotic | 1.29e-04 | 44 | 330 | 5 | C0376280 | |
| Disease | Anxiety neurosis (finding) | 1.29e-04 | 44 | 330 | 5 | C1279420 | |
| Disease | Generalized seizures | 1.44e-04 | 101 | 330 | 7 | C0234533 | |
| Disease | Clonic Seizures | 1.44e-04 | 101 | 330 | 7 | C0234535 | |
| Disease | Non-epileptic convulsion | 1.44e-04 | 101 | 330 | 7 | C0751056 | |
| Disease | Atonic Absence Seizures | 1.44e-04 | 101 | 330 | 7 | C0751123 | |
| Disease | Single Seizure | 1.44e-04 | 101 | 330 | 7 | C0751110 | |
| Disease | Visual seizure | 1.44e-04 | 101 | 330 | 7 | C0270824 | |
| Disease | Epileptic drop attack | 1.44e-04 | 101 | 330 | 7 | C0270846 | |
| Disease | Vertiginous seizure | 1.44e-04 | 101 | 330 | 7 | C0422855 | |
| Disease | Gustatory seizure | 1.44e-04 | 101 | 330 | 7 | C0422854 | |
| Disease | Seizures, Somatosensory | 1.44e-04 | 101 | 330 | 7 | C0422850 | |
| Disease | Olfactory seizure | 1.44e-04 | 101 | 330 | 7 | C0422853 | |
| Disease | Seizures, Auditory | 1.44e-04 | 101 | 330 | 7 | C0422852 | |
| Disease | Convulsive Seizures | 1.44e-04 | 101 | 330 | 7 | C0751494 | |
| Disease | Seizures, Sensory | 1.44e-04 | 101 | 330 | 7 | C0751496 | |
| Disease | Complex partial seizures | 1.44e-04 | 101 | 330 | 7 | C0149958 | |
| Disease | Nonepileptic Seizures | 1.44e-04 | 101 | 330 | 7 | C3495874 | |
| Disease | Generalized Absence Seizures | 1.44e-04 | 101 | 330 | 7 | C4505436 | |
| Disease | Jacksonian Seizure | 1.44e-04 | 101 | 330 | 7 | C0022333 | |
| Disease | Epileptic Seizures | 1.44e-04 | 101 | 330 | 7 | C4317109 | |
| Disease | Stomach Neoplasms | ERCC1 WWOX RPS21 FGFR2 RAD23A CAV1 TFAP2C NAXD CDH2 M6PR IL6R PLCE1 | 1.44e-04 | 297 | 330 | 12 | C0038356 |
| Disease | Absence Seizures | 1.53e-04 | 102 | 330 | 7 | C4316903 | |
| Disease | Convulsions | 1.53e-04 | 102 | 330 | 7 | C4048158 | |
| Disease | Tonic Seizures | 1.53e-04 | 102 | 330 | 7 | C0270844 | |
| Disease | X-21448 measurement | 1.57e-04 | 10 | 330 | 3 | EFO_0800816 | |
| Disease | X-23974 measurement | 1.57e-04 | 10 | 330 | 3 | EFO_0800867 | |
| Disease | bilirubin measurement, response to tenofovir | 1.57e-04 | 10 | 330 | 3 | EFO_0004570, EFO_0009279 | |
| Disease | response to carboplatin, response to antineoplastic agent | 1.57e-04 | 10 | 330 | 3 | GO_0097327, GO_0097328 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 1.57e-04 | 10 | 330 | 3 | EFO_0802185 | |
| Disease | Head and Neck Carcinoma | 1.57e-04 | 10 | 330 | 3 | C3887461 | |
| Disease | Malignant neoplasm of stomach | ERCC1 WWOX RPS21 FGFR2 RAD23A CAV1 TFAP2C NAXD CDH2 M6PR IL6R PLCE1 | 1.59e-04 | 300 | 330 | 12 | C0024623 |
| Disease | Tonic - clonic seizures | 1.73e-04 | 104 | 330 | 7 | C0494475 | |
| Disease | Seizures, Focal | 1.73e-04 | 104 | 330 | 7 | C0751495 | |
| Disease | Myoclonic Seizures | 1.73e-04 | 104 | 330 | 7 | C4317123 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AVCDVFVENYVPGKL | 131 | Q9HAC7 | |
| FYVQGISPCVLSEAG | 171 | Q13075 | |
| GTYELFKCPKVEVES | 466 | Q9NWW7 | |
| PSGKDVVSLYFDVCQ | 111 | Q14264 | |
| FSDPVYKEIAITNGC | 61 | Q8IV48 | |
| GYKVFFIESICNDPG | 151 | P16118 | |
| TVLVFYLPSECGEKI | 261 | P43681 | |
| PLPELCYKADVQAFS | 26 | P46092 | |
| VCYIAGFFLTVSPES | 181 | P55263 | |
| CEAEFPSKPVAEYLT | 321 | Q92754 | |
| CLYSITVPKEFVVFG | 1651 | Q96PZ7 | |
| EYKTVGLAACQEPAL | 1906 | Q96PZ7 | |
| AYDKLVQCPPESFDV | 321 | P54284 | |
| LVFYLPSDCGEKVTL | 261 | P32297 | |
| FVIPYRCLVGEFVSD | 111 | P05067 | |
| AGVTQSVPIFEGYCL | 156 | Q9BYD9 | |
| DAVTCTVPIFEGYSL | 161 | Q8TDY3 | |
| FGIPVRCYSAEVVTL | 151 | Q00535 | |
| YVENADGKIPLGTCF | 126 | Q8N888 | |
| YCFPALVVGIAAAID | 971 | O94910 | |
| NDECVATYKGVPFEV | 281 | Q12904 | |
| TGLKPVDSGCVAYVL | 401 | Q9HD20 | |
| DLCYIAAVKGAPETL | 646 | Q9HD20 | |
| YAVGDVCGKALLTPV | 371 | P00390 | |
| VQKVCLDLSPGYSDV | 36 | A8K2U0 | |
| GVSRVCLYPGFVDVK | 86 | Q96Q83 | |
| YEPAECFLLSVSVAV | 806 | C9J069 | |
| DNEGKGVLFYCILPT | 111 | Q9NU02 | |
| AGAFEISPSEILYCT | 71 | Q8TF65 | |
| PEGAICLYTKGADTV | 651 | O60423 | |
| RIAASYGNAVCIFEP | 71 | Q8TDJ6 | |
| IYEAFLVGKPSDCTL | 986 | Q7L2E3 | |
| YVHTVCDPLFEAVGK | 151 | Q03135 | |
| IADLTGQVALYTFCP | 26 | Q9NPI6 | |
| FYNPAVSRIVEAGCV | 396 | P98194 | |
| KIYISQVCEDVFSGP | 176 | Q8N2F6 | |
| FYTERAPAVIDGTQC | 661 | Q9UKP5 | |
| GCISVEPYILGEFVK | 1126 | Q96QP1 | |
| FGYVCETEFPAKAAA | 311 | Q6VUC0 | |
| LEGFVSDDPCIYIQI | 271 | Q7Z5Q5 | |
| GFPESLVIQAYFACE | 331 | P54725 | |
| YVEFCEIQSVPLAIG | 211 | Q86U06 | |
| AKFEEYGPVIECDIV | 96 | Q9BWF3 | |
| EYGCLKAIALFTPDA | 301 | P10588 | |
| GSCIFIYIKPSAKDE | 251 | Q9NZP2 | |
| LIPAITTADAGFYLC | 2011 | P98160 | |
| VSVPQCDVFGYFSIE | 866 | O95980 | |
| TFPSGEYVAEEICIA | 56 | O60674 | |
| DCLDKVIDYVPGIFQ | 176 | Q7Z3E1 | |
| CFSKDIYVVDEVLAP | 1071 | O15438 | |
| VGVPGVYTNLCKFTE | 231 | Q9Y5K2 | |
| YGIKDDVFLSVPCIL | 281 | P00338 | |
| IYVDCFGNLVPLTKS | 1381 | Q01484 | |
| LVGEEYKSIPCSVAA | 76 | Q9NWU1 | |
| EQKGLSPYCFISAEV | 1196 | O75140 | |
| ASPDYLEIAIYCIGV | 371 | P21802 | |
| YCAVIFPEFLKELAA | 926 | Q8N612 | |
| FPELGKIISDNLTYC | 191 | Q9Y2X3 | |
| VKLTDFGFCAQITPE | 416 | O75914 | |
| VYELCEVIGKGPFSV | 11 | O14936 | |
| YGAFDPLLAVADICK | 341 | Q05329 | |
| VVEYCIQALPEFDGK | 211 | Q58FF3 | |
| LLADGVCDKYNVPSV | 106 | P55771 | |
| EFGPGVIEQYCTLTI | 2856 | Q86XX4 | |
| LSIVFIEGYCTPEEV | 231 | P43363 | |
| ETLFTYQGASVILPC | 56 | Q96S86 | |
| DGVPFTVDSENKIYC | 571 | Q9UGP4 | |
| GPEVISGEKVTFYCR | 131 | O76036 | |
| FVALAIVCDEYFVPA | 466 | O60721 | |
| IVCDEYFVPALGVIT | 471 | O60721 | |
| ISQEVRGDVFPSYTC | 41 | Q08431 | |
| GKVISSYEHVQPCFI | 471 | Q6A163 | |
| PEIAVYVDLALGCSK | 1216 | Q15751 | |
| VKEEGDPTRAGICYF | 26 | Q9NQG7 | |
| CAALTTDIIEKYGFP | 986 | Q5H9U9 | |
| QGVCVLLPSAVFSVY | 81 | Q96KN9 | |
| QILAPVEADVGFYTC | 1236 | Q8N6G6 | |
| YDTFVCDSAAPGQLI | 521 | Q86UP0 | |
| ACVGDPFYKITSEAL | 526 | Q86VP6 | |
| VIPDYVLGQSTCALF | 126 | P07992 | |
| LIDFVCKQGYDLSPL | 481 | P05160 | |
| DLEDGTCKVSYFPTV | 2051 | O75369 | |
| TGGLPAAIDVAECVY | 1196 | O15055 | |
| VTLCPAGFYADESQK | 781 | P29122 | |
| AVEKGAVCPALANYL | 436 | A0A0J9YXQ4 | |
| VCLGDTNLYSYVEVP | 266 | Q9ULL4 | |
| FSNYSALVEKPVCGV | 351 | Q9UJ14 | |
| PSRFIFDCVSQEYGI | 236 | A6NDG6 | |
| LEVFYPELGNIGCKV | 46 | Q96S96 | |
| AAPCEPESLEINKYF | 36 | P25025 | |
| IKVIPNGDGTFRCSY | 716 | Q14315 | |
| EKSPFYVSFLAGCVA | 221 | Q9H936 | |
| GLGDPACFYVAVIFI | 151 | Q2PZI1 | |
| VFCASAAAPVIKAYS | 106 | Q8IW45 | |
| EPCEGAETYVNGKLV | 561 | O43896 | |
| VDILCSAGSTVYAPF | 56 | O14960 | |
| VEVSVPLKLYCNGDG | 246 | P54753 | |
| VYAGPCSQKADTVFR | 546 | P27487 | |
| IELKGLAPTCAYVFQ | 166 | Q9HCN3 | |
| PTEAFLASCYAVVPV | 331 | Q96JA3 | |
| LASCYAVVPVLDKLG | 336 | Q96JA3 | |
| SCDPVFYRQVLGAES | 791 | Q9UN70 | |
| YLQAAPVLFCALGAV | 566 | Q6IE36 | |
| DYLPLTALVDGQIFC | 151 | P62714 | |
| DYLPLTALVDGQIFC | 151 | P67775 | |
| SKDFYPGTTERVCLV | 71 | Q9UNW9 | |
| LDDYPKCFIVGADNV | 21 | P05388 | |
| AKFEEYGPVIECDIV | 96 | Q9BQ04 | |
| FKELVYETVRVPGCA | 71 | P01225 | |
| KIEDTLCPFGFEVYP | 11 | Q9Y4U1 | |
| NPSEYVVCFLGGSEK | 146 | Q9HAS0 | |
| IVCALYVPGVAFGDI | 406 | O94880 | |
| HGECVEYVKSFNIPL | 276 | O15379 | |
| EFLDKQVCGTPEYIA | 541 | Q9Y2H9 | |
| ELTGADCDPVYKVAT | 356 | Q9BRP4 | |
| PILFDCSIAENIAYG | 1126 | P21439 | |
| FPAVVKLVCGDITVY | 181 | Q8NHA4 | |
| FLEEVTPAQGGIYRC | 86 | Q8IYS5 | |
| CFYQPGTTVLISDED | 1076 | Q2VWP7 | |
| CVSDFRTGINLPYIV | 81 | Q8NB91 | |
| KELFCEYGPTESVKV | 216 | Q96DU9 | |
| EVSNYLFPDCRVISG | 226 | Q8IVS2 | |
| VPFEDGKQFELCIYV | 81 | Q9UHV8 | |
| ASDLYCPIFKLGFIV | 231 | Q9UBL9 | |
| ADAGLVCITSFISPY | 121 | O43252 | |
| LGVLEKIQAYPEAFC | 566 | Q7L622 | |
| SAEGEEVQLCFSIYP | 1376 | Q9P2D7 | |
| IPYEFTDGDLRICIS | 3841 | Q9P2D7 | |
| PSTFISDIINCGIYL | 171 | Q96IJ6 | |
| SDIINCGIYLFSPEA | 176 | Q96IJ6 | |
| FLTVLVFYLPSDCGE | 256 | Q15825 | |
| VFYLPSDCGEKVTLC | 261 | Q15825 | |
| VFYLPSNEGEKICLC | 271 | P30532 | |
| GATSLCVVYPLDFAR | 136 | Q9H0C2 | |
| VSFCEDKDTGEPVIY | 781 | Q3L8U1 | |
| TPKACVIVYYIEDDG | 526 | Q6YHK3 | |
| IVENTYFCPVLATGL | 236 | Q05DH4 | |
| PDFPDVSSGVYVCKV | 401 | P83105 | |
| LVCLISDFYPGAVTV | 26 | P0CG04 | |
| KATLVCLISDFYPGA | 131 | B9A064 | |
| NDSAIYICGIAFPSV | 111 | O95976 | |
| CQLAVPEGDSSFYIV | 176 | P08887 | |
| AAYLPTKLAAVACVG | 106 | Q9P2D3 | |
| VCGAIYTGLFLPETK | 446 | Q9BYW1 | |
| YSCVPVALAEGLDIK | 571 | O60341 | |
| DFSCKIVPYIEVASL | 331 | O15354 | |
| YDAVTGKFTCQVPGV | 136 | Q9BXJ0 | |
| CFGAEFVEVIKDSTP | 1836 | Q8NF50 | |
| IEEDGKLYLCVSSPT | 396 | Q7Z5Q1 | |
| DLTGFSYEDLIPCVL | 476 | P41002 | |
| GRKVFELVGEPSIYC | 201 | P17927 | |
| GRKVFELVGEPSIYC | 651 | P17927 | |
| GRKVFELVGEPSIYC | 1101 | P17927 | |
| EEDGKLYLCVSSPTI | 506 | Q8NE35 | |
| GFEVKAYANPTVVRC | 481 | Q86XK2 | |
| CTQDGPLYVIVEYAS | 551 | P11362 | |
| GLSAESYPIIKGVAC | 531 | Q7L775 | |
| VVGLTVVYAFCTLPE | 361 | O60883 | |
| DVYQASVGFVCESPT | 206 | Q96JB5 | |
| KCPAYPTELVFALDN | 1751 | A8TX70 | |
| VFELVGEPSIYCTSK | 196 | Q2VPA4 | |
| LVCLISDFYPGAVTV | 26 | P0DOY2 | |
| PLFEKVACQGVISYD | 576 | Q8TDW7 | |
| LVCLISDFYPGAVTV | 26 | P0DOY3 | |
| LVCLISDFYPGAVKV | 26 | P0CF74 | |
| GVPLACNYVKLEDVA | 466 | Q9ULC5 | |
| NSVEKFYIPGGDVTC | 26 | Q13137 | |
| IAAFESVPTAIYCFL | 271 | Q9NX46 | |
| LSFQAVCREGIVEYP | 561 | Q92496 | |
| VFGYPCEAAAEIVLA | 271 | Q9BQ69 | |
| CKYDFNLEGVVDVPE | 356 | O43148 | |
| REFLDKQVCGTPEYI | 736 | O15021 | |
| GVACVAFSPSAKYIV | 136 | O60336 | |
| QTPEGVYCLVGFILT | 226 | P11245 | |
| GCLDYETAPQFTLLI | 231 | Q8IXH8 | |
| IIVVKDGPGFYTTRC | 536 | P40939 | |
| PEYKGVVSVCFEGDS | 71 | Q92551 | |
| PSAAEAIKVCGSYLL | 571 | Q76NI1 | |
| AVYKIFDDSPCPFTA | 391 | Q8IWA5 | |
| FVCEYASPGKATEVR | 56 | P16410 | |
| LQKLSEDPYGIFCLV | 61 | Q9Y6V7 | |
| IEEDGKLYLCVSSPT | 536 | Q17RY0 | |
| GTAALGCLVKDYFPE | 21 | P01857 | |
| STAALGCLVKDYFPE | 21 | P01859 | |
| GTAALGCLVKDYFPE | 21 | P01860 | |
| TCLVKGFYPSDIAVE | 296 | P01860 | |
| STAALGCLVKDYFPE | 21 | P01861 | |
| TCLVKGFYPSDIAVE | 246 | P01861 | |
| IAPVTKEDIGNYSCL | 206 | A8MVW5 | |
| QGLLYGVPVSLKECF | 131 | O00519 | |
| EERTPYIVVAFQECG | 4246 | Q9NYC9 | |
| ECIIANPAFVVYSSI | 181 | P14416 | |
| AIATVCGSRNYPFDI | 1241 | Q5TBA9 | |
| RIIFSYVQLDPDGSC | 71 | Q86UP6 | |
| AADATLVFIGYVVPA | 186 | Q96CH1 | |
| FCDVLPGKESLGYFV | 251 | Q9NQC7 | |
| PELDYFVVFSSVSCG | 2011 | P49327 | |
| LPSAKDLVFEEACGY | 396 | Q86YV9 | |
| DKGITTAAVCVYPAR | 91 | Q9Y315 | |
| EQGVCYLVLCEAAFP | 66 | O75396 | |
| PQYFLLTCGEVVFSV | 586 | P46059 | |
| PEIKYGESLCFVQHV | 336 | P21817 | |
| IAFSICPAKGTVEAY | 896 | Q6ZTR5 | |
| VYVCKPTFVGSRDQD | 281 | Q9UBP4 | |
| VSTPAGKIGLAVCYD | 191 | Q86X76 | |
| LCKTGFPEDVYSAVL | 31 | P19022 | |
| TTYVGFCLPFVVLDI | 46 | O95992 | |
| FSKSDPICVLYVQGV | 41 | Q86YQ8 | |
| IGVVTYEKSCVFPYD | 341 | Q8NG08 | |
| FEAYTKICDPGLTSF | 446 | Q13555 | |
| LGFYVEGLKSVPCEN | 186 | B7ZC32 | |
| GSVAGVRYFQCEPLK | 101 | P30622 | |
| VLALSAIPGAIDYCT | 176 | O75911 | |
| EPEYVCVGSIALYTA | 1186 | Q8TE73 | |
| ELKLFTEYPCGSGNV | 271 | Q8IU81 | |
| FEAYTKICDPGLTAF | 366 | Q13557 | |
| KTVVCYPIIFDLSDF | 571 | Q93100 | |
| VPCTVLEAFAAAYKG | 271 | Q15077 | |
| LEVYDLCLAFLGPAT | 961 | Q5VU65 | |
| IPLLVKNSTCYDAGE | 41 | A6NGG8 | |
| LLYVDSVGFNGKPEC | 371 | Q8TE04 | |
| PVGYTGAFCDVDTKA | 201 | P00748 | |
| FIVRFVCNDDVYSGP | 1036 | P11717 | |
| PFIFNGKSYEECIIE | 1906 | P11717 | |
| PLRAGSLDTYVQCFV | 436 | Q8IYJ3 | |
| EVCHFGYIITEIPSL | 106 | Q5TCS8 | |
| IIAALIKPFGQCYEF | 251 | Q93008 | |
| LDDYPKCFIVGADNV | 21 | Q8NHW5 | |
| EVPVISGAFCYDVVL | 171 | Q9NYK5 | |
| YVEILPSDGKDQFSC | 56 | Q9Y5X1 | |
| RYVKQFPEDGSVCTL | 526 | Q9HCB6 | |
| DSYAGSIPLLIIAFC | 486 | Q695T7 | |
| AICLDYFTDPVSIGC | 21 | Q8WV44 | |
| CAVDPASYLVKVGVG | 596 | Q7Z4K8 | |
| TYDFACPIVDSIEGV | 376 | P07814 | |
| LGFEPVYVSCIAQDT | 111 | Q99932 | |
| VDAETSALGYFITPC | 186 | Q14542 | |
| APIECYNRISGALFT | 501 | A6NHR9 | |
| VTAVPCDDKIFYNSG | 516 | Q9H7E2 | |
| KLHCFQLTVTPDEGY | 61 | Q969M7 | |
| CNIVLKTYVPDGFGD | 816 | Q15147 | |
| GEFVDLYVPRKCSAS | 6 | P63220 | |
| NVCIRFEVSPSYVKG | 166 | P28370 | |
| EPISKCGDLDVIFEY | 346 | Q17RD7 | |
| SVTVPDVKYVIDFCL | 451 | Q8NDG6 | |
| PEVKDSLGVYCIDAY | 116 | Q9Y4C2 | |
| ASVYCFEPVSEVGVK | 331 | Q9Y4C2 | |
| SFGYEVPFIVLGCVV | 191 | Q6NT16 | |
| LFDVYAVPCNRSGSE | 1236 | Q9P212 | |
| SDLVIYCQAVKFPGL | 1666 | Q9P212 | |
| PLSECQEGKVIYTAF | 291 | Q9H0K6 | |
| TEKAAVLSCYAVFPF | 286 | Q9Y289 | |
| IPDSGCSYLTVLFEE | 426 | Q7RTZ1 | |
| PDTFVRTIYAGNALC | 141 | P13804 | |
| LCTAKEIADPTYEVG | 346 | Q5VWT5 | |
| DLYVTCQVFAEGKPL | 56 | Q8NEB9 | |
| IYAVNGTEILLPCTF | 41 | Q8IWT1 | |
| TVGFVDCLYGTVPKL | 896 | O94933 | |
| QALSTLECVKPYLEG | 1881 | P58107 | |
| VFGANVEKLICEPYT | 506 | O43490 | |
| PVFCVVEQLDGSLEY | 61 | Q9UPW6 | |
| VQEGLCVLVPCSFSY | 31 | O15389 | |
| GVVLYVLVCGSLPFD | 211 | A0A0B4J2F2 | |
| GVVLYVLVCGSLPFD | 211 | P57059 | |
| PFDSGVYTCKAINVL | 446 | Q13203 | |
| PEEDAGKLYNTCAVF | 86 | Q9NQR4 | |
| TCAVFGPDGTLLAKY | 96 | Q9NQR4 | |
| VYVPSVRGSKFVVDC | 441 | Q75T13 | |
| AKGVFLECLEPYILS | 611 | Q8N3P4 | |
| FIDEKSDGFVYCPVN | 531 | Q8NEZ3 | |
| PSELRYFVKDVLGCV | 541 | Q14181 | |
| YITERIIAVSFPAGC | 11 | Q68CZ2 | |
| IIAVSFPAGCSEESY | 16 | Q68CZ2 | |
| GTEEESFITPLVLYC | 61 | Q8TBJ4 | |
| EEGIPAFTCEEYVKS | 186 | Q9Y2L1 | |
| LAVAIGADCTYPELT | 791 | Q9Y2L1 | |
| LLVDCYKPTEAFISG | 116 | Q96C90 | |
| LAPIYFGALIDTTCI | 586 | Q9Y6L6 | |
| LVEPACGAALAAIYS | 271 | Q96GA7 | |
| FGLEVCLAAGITYVP | 26 | Q96JT2 | |
| VCPDGKLYLSVAGVS | 266 | Q13326 | |
| LAILVFYLPSDCGEK | 251 | P17787 | |
| YLPKLASGETVAAFC | 201 | P49748 | |
| TGSPKAEVQLCYLEA | 906 | Q13023 | |
| SPCLIDYDFVGKFES | 336 | Q9H2A9 | |
| PCQIDYDFVGKLETL | 331 | Q9NRB3 | |
| SLEEVCVYHSGVPIF | 171 | Q9UHD1 | |
| AKYCSEILGVAATPG | 601 | Q9BYT8 | |
| SGVCYAEFGVRVPKT | 101 | Q8TBB6 | |
| KDYVCSQFPTPEAVL | 571 | Q7KZ85 | |
| ETPETFYIGKLIICN | 1156 | Q7KZ85 | |
| IGAAVSFPYVIALDD | 251 | Q8WUH2 | |
| FEVEIVDPGEKCYIA | 261 | Q8NCJ5 | |
| VVGLSVACSYLSPKD | 461 | Q70EL4 | |
| FLDPFDTCGLIVAKY | 146 | Q9HAW8 | |
| VAEYPAEKLAFSAVC | 291 | O14924 | |
| CPALVYTNLITFSEE | 656 | Q9NZQ8 | |
| PVSEERGKVQDCFYL | 156 | P20645 | |
| SGIRAYFEVIPEQKC | 351 | Q7RTY8 | |
| CIEVYAPGFKDSVVG | 486 | Q8N2H3 | |
| AACFIAIVPGYISRS | 201 | Q8TCJ2 | |
| VFVIKPEDYACGGSF | 261 | Q9NXL6 | |
| ACGNKVDPVYETLRF | 191 | Q99469 | |
| LQFEGSVEVYAPFCS | 326 | Q9NPI9 | |
| VVFYQTPGLEVTACV | 1166 | Q9Y2I1 | |
| RSEGNPVAFCIFEYV | 271 | Q06203 | |
| IEFIYTAPSSAVCGV | 86 | P16035 | |
| LACEEAPGVFYLAGI | 691 | Q7Z410 | |
| GGIEICITFPTEYVK | 36 | P53007 | |
| CVNFIESALPYVVGK | 406 | P78562 | |
| FYIACDNIGTPLAVF | 2356 | Q6N022 | |
| AATTVYCAAVPELEG | 356 | Q9NZC7 | |
| IPQGERKTVTDFCYL | 51 | Q8N9R8 | |
| CPLFEGIGYATQVIE | 126 | P48066 | |
| DTQILPFTCAYGLVL | 206 | A8MV23 | |
| VLTVLCNVAEKGPAY | 401 | Q96DC7 | |
| IPGSAVCAFYLDEIE | 326 | Q9H3T2 | |
| LCGEELSYPNVFLVF | 526 | Q9NW08 | |
| GQDVPYVLKSCAEFI | 31 | Q2M1Z3 | |
| ICLITDPFLDIYFSG | 231 | Q9H0V1 | |
| FSEYLLECPSAEVRG | 2101 | O00507 | |
| QYETIGLDFTIPKSC | 1086 | Q14997 | |
| LPLDGETVKYCVDVY | 76 | Q86X10 | |
| FCCDLKGIDVVVPYF | 571 | Q86X10 | |
| EIKVLGPYTFSICDT | 266 | P22314 | |
| LDKEVGYCQGISFVA | 1001 | O60343 | |
| KAFQAEESPGVIYCI | 806 | Q9Y2K6 | |
| PSNTFVLEYCGEVLD | 1571 | Q9BYW2 | |
| KDRFVAYPCAVGQTA | 331 | Q9Y577 | |
| REPVCKVGVFLDYES | 401 | Q8N9V2 | |
| IIVPFVTCGDLSSYD | 231 | Q9UET6 | |
| VFCNGAVPTELALLY | 136 | Q96HH6 | |
| QTLKDPIVSIGFYCT | 381 | Q7Z7G8 | |
| FLYLCGFQEPDSILV | 121 | Q9NQH7 | |
| YKFTVTACGLPDVAV | 1186 | O43149 | |
| LFGASLEKCDYINVP | 501 | Q86VQ6 | |
| IVFADAYLPCGELLA | 146 | P36537 | |
| LCDGTPVVYIFQLDA | 261 | P57081 | |
| GLVVLDCPTDACFVY | 236 | Q9BZW4 | |
| VCVFLVATYTDGLPT | 131 | Q9NV66 | |
| NPDFIEVKGVTYCGE | 596 | Q9NV66 | |
| SCPLGEEEYTFSLKV | 231 | Q9C0I4 | |
| YALCSFFVPGDRQVV | 456 | Q9UNX4 | |
| PVTDGYIVCEEFKDV | 806 | Q01831 | |
| NEYEIIHTGEKPFTC | 211 | B4DXR9 | |
| FYVRQAEKVIDGTPC | 356 | Q6ZMP0 | |
| YSAVVADFGLAEKIP | 191 | Q96S53 | |
| DPYILIAAGSICFAN | 291 | Q05940 | |
| KDLFVPACLETGEYA | 1101 | P01266 | |
| KDVSGFSDPYCLLGI | 126 | Q70J99 | |
| VQEGLCVLVPCSFSY | 31 | Q08ET2 | |
| CVFLVATYTDGLPTE | 86 | Q6NUM6 | |
| GNPDFIEVKGVTYCR | 531 | Q6NUM6 | |
| DACGLIVAKYFSLPS | 151 | Q9HAW7 | |
| DACGLIVAKYFSLPS | 151 | Q9HAW9 | |
| QGLFVYPLDECTTVI | 46 | Q5TIE3 | |
| YPLDECTTVIGFEAV | 51 | Q5TIE3 | |
| AVVAVPTDTLYGLAC | 81 | Q86U90 | |
| CEGLTKQASIFIPVY | 991 | Q9BYP7 | |
| DVVKCSLGQPHIAYF | 291 | Q13287 | |
| VYICEFATFPTGNRE | 121 | Q15223 |